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INTRODUCTION 
Fungi constitute a vast and diverse group of eukaryotic, heterotrophic, 
spore producing, single celled or multi-celled organisms that live by decomposing 
and absorbing the organic material in which they grow1. Although there are over 1.5 
million species of fungi on Earth, only about 300 of those are known to cause 
infections in humans. 
Pathogenic fungi are those which are capable of causing disease in humans. 
They do so because of their specific metabolism and enzymes systems, which 
allows them to survive at elevated body temperatures and helps to overcome the 
host defense mechanisms
2,5
. 
Otomycosis 
Otomycosis is a superficial, fungal infection of the external auditory 
canal
2,4
. Otomycosis is challenging for both patients and otolaryngologist as it 
frequently requires long term treatment and follow up. Inspite of proper treatment 
and follow up, the recurrence rate remains high
3,6
. 
Causative Organisms 
Aspergillus and Candida are the most common organisms causing 
otomycosis
2,5,7
. Among Aspergillus species, Aspergillus niger is usually the 
predominant species, followed by Aspergillus flavus, Aspergillus fumigatus and 
Aspergillus terreus
7,9
. Among Candida species, Candida albicans is the most 
common isolate followed by Candida parapsilosis, Candida glabrata,    Candida 
guilliermondii and Candida krusei. Other fungi like Penicillium, Mucor, Rhizopus, 
Cladosporium, Chrysosporium and Absidia are also involved
2
. 
The different species of fungi have varying susceptibilities to the 
commonly used antifungal drugs. Aspergillus fumigatus, Aspergillus terreus and 
non-albicans Candida show high degree of resistance to antifungals 
8
. Hence it is 
very important to identify and speciate the causative fungi, as it will help in 
choosing appropriate antifungal drugs for effective therapy. 
In recent years there has been an increased awareness about fungal 
infections and a high degree of clinical suspicion among doctors in diagnosing 
otomycosis. More in-depth studies on the various otomycosis causing fungi and 
their degree of sensitivity to currently available antifungal drugs will help the 
clinician in diagnosing and refining treatment of otomycosis. This study will give 
us insights into the various fungi causing otomycosis in this region, their virulence 
factors and susceptibility to commonly used antifungal drugs.  
 
 
 
 
 
 
AIM 
• To isolate, identify, speciate and characterise the fungi isolated from 
patients with clinically suspected otomycosis.   
OBJECTIVES 
 
• To determine the prevalence of fungi causing otomycosis. 
• To analyse the distribution of fungal species causing otomycosis. 
• To identify the predisposing factors for otomycosis. 
• To characterise the isolated fungal species. 
• To determine the antifungal susceptibility pattern of the isolates. 
 
 
 
 
 
 
 
 
  
REVIEW OF LITERATURE 
 
Historical perspectives:  
 
In 1835, Agostino Bassi discovered that a disease of silkworms was caused 
by a fungus, Beauveria bassiana. In 1841, David Gruby demonstrated that Favus, 
an infection of the scalp in humans, was caused by a fungus. By 1890, Raymond 
Jacques Adrien Sabouraud, the “Father of Medical Mycology” published 
numerous articles on fungal disorders of the skin, making huge contributions to 
the field of Medical Mycology. 
 
Andrall and Gaverret, in 1843, were the first to describe fungal infection of 
the ear canal. The first article on “Otitis Externa” was written by Meyer in 1844. 
In 1851, Pacini described various preparations for the treatment of otomycosis. 
The term “Otomycosis” was suggested by Virchow in 1856, to describe superﬁcial 
fungal infections of the ear canal
2
. Wolf in the early part of the 20
th
 century 
published a list of 53 fungal species causing otomycosis. 
 
Otomycosis: 
The term Otomycosis typically describes a superficial fungal infection of 
external auditory canal. The infection may either be subacute or chronic
3,17
. It is 
generally unilateral. Otomycosis is also known as Swimmer‟s ear or Singapore 
ear.  
Occurrence of otomycosis in immunocompetent individuals is usually 
associated with presence of a predisposing condition
4
. Immunocompromised 
individuals like patients with Diabetes mellitus, HIV or lymphoma and patients 
with carcinoma on chemotherapy or radiotherapy are at an increased risk for 
developing complications associated with otomycosis
10,21
. 
 
Epidemiology 
Based on various studies, an estimated 5 – 30 % of the cases of otitis 
externa are due to otomycosis
2,11
. The prevalence of otomycosis is related to the 
geographic distribution, with tropical and sub-tropical areas showing higher rates 
of incidence
12,13
. It has a high prevalence of over 54% in tropical regions and a 
low prevalence of around 9% in temperate zones
14,15 
. 
 
Higher incidence of otomycosis is seen during the rainy months followed 
by summer, as warmth and moisture provide a highly favourable environment for 
growth of fungi
16,17
. Otomycosis usually has a chronic course with acute episodes 
and intermittent remissions
18
. 
 
Habitat 
The fungi causing otomycosis are commonly saprophytes present in soil, 
compost, mouldy cereal grains, etc. which serve as a source of infection
19
. These 
fungi present in the environment, can remain as commensals in the exposed parts 
of the body and cause opportunistic infections when the conditions in the ear canal 
are altered or when the immune status of the host is compromised.  
 
 
Pathogenesis:     
Mayer was the first to draw attention to infections of the external ear by 
fungi as early as the middle of the nineteenth century. The pathogenesis behind 
otomycosis is related to the anatomy, histology and physiology of external 
auditory canal. Being open on one side, the auditory canal is constantly exposed to 
fungal spores present in the atmosphere. Inspite of constant exposure to fungi, the 
auditory canal is protected by certain protective factors. 
 
The inherent defence mechanisms of the ear canal include: 
1. The conchal cartilage, narrow isthumus covered by hair and tragus partially 
covering the opening of the ear canal, prevent entry of contaminants into 
the ear canal 
4,6,12
. 
2. The skin over the ear canal has a migratory property, which plays an 
important role as a self-cleaning mechanism. In 1882, Blake published 
several studies on the migratory nature of desquamated canal skin. Alberti 
in 1964, studied this property further and measured the rate of migration at 
0.07 mm/day. As the stratum corneum reaches the cartilaginous portion of 
the canal, it is lifted up by the action of the hairs and the secretions of the 
sebaceous and ceruminous glands. This mass of desquamated epithelial cell 
debris and secretions coats the outer portions of the ear canal and is 
commonly known as the cerumen or earwax
20
. 
3. Cerumen or Ear wax consists of desquamated keratin, peptide and lipid 
secretions from the ceruminous and sebaceous glands. It also contains 
lysozyme, hyaluronic acid and immunoglobulin G, which helps in 
inhibiting bacterial and fungal growth. Cerumen has a protective role in the 
External auditory canal. Cerumen creates an acidic environment with a pH 
of about 5.7 in the external ear canal preventing growth of micro 
organisms. It is also hydrophobic, repelling water making the surface of the 
canal impermeable and thus avoiding maceration and epithelial damage. In 
addition to this, the sticky nature of the cerumen helps to trap fine 
debris
6,20
.  
 
Breakdown of the skin-cerumen barrier is the first step in the pathogenesis 
of otitis externa. Inflammation and edema of the skin leads to obstruction and 
pruritis. Pruritis encourages scratching which creates further injury. This sequence 
of events alters the quality and amount of cerumen produced, impairs epithelial 
migration, and increases the pH of the ear canal. The resulting warm, alkaline and 
moist ear canal becomes an ideal breeding ground for numerous organisms.  
 
Fungal infection occurs only when the conditions are favourable, such as, 
presence of moisture and existing inflammation of the external ear which may 
favour the growth and inflammation due to fungi
21
. 
Direct fungal damage on tissue may occur due to tremendous force of 
hyphal extension into cells. Wolf and Castellani assert that inflammation can be 
caused by toxins secreted by the fungus. The fungi secrete various metabolic 
products such as mycotoxins  and enzymes like phospholipases, elastase and 
hemolysins
9,22,23
. These factors facilitate adherence and cause hydrolysis of cells 
of the host contributing to its virulence
24,25
. 
 
Mycotoxins, are secondary metabolites produced by many species of 
fungi, that are toxic to humans and animals.The most important mycotoxin 
produced by the Aspergillus group of fungi are the aflatoxins
26,27
. There are over 
16 types of aflatoxins. The important ones are aflatoxins B1, B2, G1, and G2 of 
which aflatoxin-B1 is the most toxic.  Aflatoxin has carcinogenic, mutagenic and 
immunosuppressive properties
28
. Aflatoxin B1 is a category 1 human carcinogen 
which usually enters the body through ingestion or occasionally by inhalation. 
Recent studies have demonstrated property of aflatoxin B1 to enter the body by 
permeating through the skin
29,30
. 
 
In immunocompromised patients, complications like invasive otitis externa 
can occur 
31,32,33
. Complications like tympanic membrane perforation, mastoditis 
with bone erosion are also known to occur
10,37
. The pathophysiology of the 
tympanic membrane perforation is attributed to avascular necrosis of the tympanic 
membrane as a result of mycotic thrombosis in the adjacent blood vessels
10,34,37
.  
 
Malignant otitis externa is frequently caused by Aspergillus fumigatus. 
Other rare causes of fungal malignant otitis externa are Aspergillus niger, 
Scedosporium apiospermum, Absidia corymbifera, Pseudallescheria boydii, 
Candida ciferri and Malassezia sympodialis
2,35,36,42 
. In Australia, Ling and Sader 
(2008) reported a case of fungal malignant otitis externa caused by Aspergillus 
flavus. 
 
Predisposing Factors 
The fungi producing otomycosis are mostly saprophytic in nature
4
.Various 
factors favour transformation of saprophytic fungi into pathogenic fungi
2,4,5,6
. 
These include: 
1. Environmental factors like heat, humidity and moisture36. Excessive 
sweating during summer dilutes wax and reduces its protectiveness. Fungal 
spores found abundantly in the environment, are blown in the wind along 
with soil particles and carried by water vapours, increasing prevalence of 
otomycosis during rainy season when the relative humidity is as high as 
80%
3,34 
. 
2. Increase in pH level in External Auditory Canal as occurs during 
swimming
38
. Water in the ears cause alteration in the pH and composition 
of the cerumen and predisposes to epithelial damage and proliferation of 
microorganisms. 
3.  Systemic factors Prolonged use of broad spectrum antibiotics, steroid 
usage, immunocompromised host, diseases like diabetes, malnutrition in 
children and malignancies. Co-morbid conditions like Diabetes mellitus 
due to alteration in the immune status and elevated glucose level in tissues 
increases the likelihood of fungal otitis. Patients with diabetes are more 
susceptible for development of complications like invasion and malignant 
fungal otitis externa
39,40
. 
4.  History of chronic suppurative otitis media (CSOM), bacterial otitis and 
postsurgical mastoid cavities
41,44,69
: In CSOM, the pus serves as a source of 
food for the fungus promoting its growth
31
. Chronic ear discharge also 
creates a humid condition in the ear, altering the pH to alkaline which 
along with the epithelial debris favours growth of fungus
41
. 
5. Epithelial damage due to trauma: Habitual cleaning with unsterile material 
and instrumentation of ear, is one of the predisposing factors to 
otomycosis
2,11,44
. Habit of cleaning ear with such contaminated objects 
leads to inoculation of fungal debris in external auditory canal 
9,22,44 
. 
6. Instillation of oil in ears: Coconut oil is reported to have sporostatic action 
and therefore may help preserve the viability of fungal conidia deposited in 
the external ear and indirectly contribute to occurrence of otomycosis
3,45
. 
7. Use of topical Antibiotics: Use of topical fluoroquinolone antibiotics 
especially ofloxacin otic drops has been reported as a predisposing factor 
for otomycosis
46
. Prolonged use of topical antibiotics or steroids ear drops 
causes suppression of the bacterial flora with subsequent emergence of 
fungal flora, causing fungal superinfection 
16,46,47
. 
8. Changes in epithelial layer like dermatological diseases and fungal 
infections elsewhere in the body like dermatomycosis 
11
: Otomycosis is 
known to occur in patients with untreated dermatomycosis or untreated 
fungal infections like onychomycosis, vaginal candidiasis, due to 
autoinoculation during scratching of ears 
38,48
. 
9. Social habits like wearing traditional head covers49. It causes an increase in 
humidity and moisture in the ear canal
50
. 
Symptoms
119 
 
The most common symptoms include:  
1. Aural Pruritus4. 
2. Otalgia: Less compared to bacterial otitis. 
3. Aural fullness or Ear block. 
4. Tinnitus. 
5. Hearing impairment and  
6. Scanty ear discharge. 
In case of invasion of the middle ear and mastoid, there can be deep pain 
and facial palsy due to invasion of the facial nerve
2
. 
Signs
2
:  
Otoscopic findings in otomycosis are as follows: 
 The ear canal usually appears edematous and erythematous7. 
 Aspergillus niger spores appear as fine, black coal dust sprinkled in 
the ear canal. Characteristic findings in Aspergillus otomycosis is 
presence of mycotic elements mixed with epithelial debris covering 
the auditory canal and sometimes the tympanic membrane, 
resembling "blotting paper" or "wet newspaper"
2,51
.  
 Candidal infections may present as soft, white, creamy material 
filling the ear canal
52
. In severe cases, the ear canal is inflamed and 
edematous.  
Clinical Classification of Otomycosis
12
 
OTOMYCOSIS 
 
Primary otomycosis   Secondary otomycosis 
       
        
 
 
 
 
Without otitis externa     With otitis externa 
 
  
 
 
 
 
 Immunocompetent 
individual 
 Intact tympanic 
membrane 
 Absence of any other 
external or middle ear 
pathology 
 H/o pre-existing otitis 
media / externa, trauma 
 H/o previous ear surgery 
 H/o fungal infections 
elsewhere in the body 
Presence of clinical 
signs of external 
otitis like local 
inflammation or 
stenosis of canal. 
Absence of signs of 
otitis externa like 
inflamed canal wall 
or stenosis of the 
auditory canal. 
Causative Organisms 
Gregson and La Touche (1961) stated that fungal organisms were 
predominantly species of Aspergillus or Candida.  
 
Medically Important Fungi Causing Otomycosis
2
 
1. Filamentous fungi with septate hyphae: 
 Aspergillus niger 
 Aspergillus flavus 
 Aspergillus fumigatus 
 Aspergillus terreus 
 Aspergillus versicolor 
 Aspergillus nidulans 
 Penicillium species 
 Cladosporium species 
  Scedosporium apiospermum 
 Fusarium solani 
2.  Filamentous fungi with aseptate hyphae: 
 Mucor species  
 Rhizopus  
3.  Yeasts and Yeast-like fungi: 
 Cryptococcus neoformans 
 Candida albicans 
 Candida parapsilosis 
 Candida glabrata 
 Candida guilliermondii 
 Candida auris 
 Candida krusei 
4. Dermatophytes: 
 Trichophyton mentagrophytes 
 Trichophyton rubrum 
 Microsporum canis 
 Epidermophyton floccosum 
 
Species of Aspergillus account for 90 - 95% of the mould isolates. 
Aspergillus niger is the most common isolate followed by Aspergillus fumigatus 
and Aspergillus flavus 
43, 53,54 . 
Wolf (1947) found that Aspergilli are responsible for about 90% cases of 
otomycosis.
 
Other fungi isolated were Penicillium, Candida and Mucoraceae. 
 
 
Fungi: Opportunist / Contaminant or Commensal ?
55 
Opportunistic fungi are widely distributed in the environment. Hence a 
reliable diagnosis requires more than just a simple identification of the organism 
on culture. To prove that the fungi is indeed an opportunist and not just a 
contaminant / a commensal the following criteria has to be met 
55,56
. 
 The symptoms should be consistent with a fungal infection. 
 Fungal structures should be seen in direct examination of the specimen 
which is compatible with the morphology of the fungus isolated in culture. 
 The fungus should be isolated in cultures from the clinical sample, 
preferably from two samples from the infected site. 
 Morphology of the isolated fungus should be consistent with the symptoms. 
 Validity of the diagnosis is maximum when fungal elements are seen in 
direct examination of the specimen and when the organism is isolated from 
multiple cultures of the infected material. 
 
LABORATORY DIAGNOSIS 
Collection of samples:  
 
Two sterile cotton swabs are used for collecting debris, fungal elements and 
earwax from the external ear canal of patients showing symptoms of otomycosis. 
If syringing was done, the aspirate can be used as specimen. Samples should be 
processed immediately. 
 
The diagnosis can be made by direct microscopy and culture. 
Histopathology may be required in some cases
18
. 
Processing of  samples.
53
 
Filamentous fungi can be identified by: 
1.) Direct Examination of Samples: It can lead to an early presumptive 
diagnosis. If sufficient material is not provided, culture is preferable as it is 
more sensitive.  
 Direct Microscopic examination of the debris in 10% potassium 
hydroxide: It can be done to look for fungal hyphal elements.  KOH acts 
as a clearing agent, dissolving the cellular debris without affecting the 
fibrillar glucan and chitin structure of the fungal cell wall.  
 Microscopic Examination using Calcofluor : Can be used with or 
without KOH to increase the sensitivity and specificity of detecting fungi 
in clinical specimens but requires the use of a fluorescence microscope
42
. 
Calcofluor fluoresces when exited with ultraviolet light at a emission 
wavelength of 450 nm and excitation wavelength of 347 nm. It binds to 
chitin, cellulose and other ß-1,4 linked polysaccharides and produce 
bright fluorescence. If Evans blue counterstain is used fungal elements 
appear blue against a red background.  
 Direct Gram stain is done to look for yeast cells. 
 
2.) Fungal Culture:  The specimens are cultured on two sets of Sabouraud's 
Dextrose Agar (SDA) with a pH of 5.6 containing antibiotics Gentamicin 
50 μg/ml or Chloramphenicol 50 μg/ml. Emmon‟s Sabouraud Dextrose 
Agar with a reduced dextrose content of 20 gms/litre and a pH of 6.9± 0.2 
can also be used. The neutral pH of Emmon‟s SDA increases retrieval of 
fungi. These are incubated at 25°C for a period of three weeks. All cultures 
are checked every day during first week and twice a week during the next 
two weeks. The mycelial isolates are identified by their colony 
characteristics and microscopic appearance by making a teased 
Lactophenol Cotton Blue (LPCB) stained mount. Fungi can also be 
cultured on Potato Dextrose Agar  (PDA) which promotes sporulation. 
 3.) Riddle’s Slide culture: is also done to study the morphological details for 
identification. Slide culture provides greater clarity and details of the fungal 
elements without distortion
53
. 
 
4.) Banana Peel Culture57: Fungi belonging to ascomycetes, basidiomycetes 
and coelomycetes can be cultured on ripe banana peel. Autoclaved pieces 
of banana peel can be used as a cheaper and readily available substrate 
which promotes growth of slow growing fungi as well as production of 
sexual spores.  
 
5.) Scotch Tape Mount/ Adhesive Cellophane Tape Method53: A drop of 
Lactophenol Cotton Blue solution is placed on a slide. Wearing gloves a 3 
cm length of the cellophane tape is held between 2 fingers. The sticky side 
of the tape is then placed over the top of the fungal colony. A part of the 
colony adheres onto the tape. The tape is then placed on the slide covering 
the LPCB solution. Both ends of the tape are then pressed onto the slide. 
This method provides a better picture of the fungal morphology compared 
to the Tease mount. 
 
6.) Automated Systems53 :  
 Mycosis IC/F Medium and the BACTEC System 
 BacT/ALERT-D  
Yeast isolates can be identified by the standard tests like
111
: 
 Gram stain: Shape and Size of cells, Type of Budding, Presence of 
Arthroconidia 
 Germ tube test 
 Culture characteristics : Colony colour, shape and texture,  
 Morphological characteristics on Corn Meal Agar, 
 Colour of colony on CHROM agar58, 
  Sugar fermentation tests, 
 Sugar Assimilation tests, 
 Nitrate Assimilation tests, 
 Urea Hydrolysis test, 
 Rapid Tests for Yeast Identification  
 
 BactiCard Candida: Measures N-acetyl galactosaminidase and L-
proline aminopeptidase activity for identification of Candida albicans 
 Rapid Trehalose Test for Candida glabrata 
 Commercial Yeast identification Panel Kits: 
 API 20C 
 VITEK 2 YST 
 Rapid Yeast Plus 
 Peptide Nucleic Acid - Fluorescent insitu Hybridization (PNA-FISH) 
 MicroScan Rapid yeast Identification Panel 
 
Tests for Virulence
59,60
 
a) Proteolytic activity
22
: Can be tested by inoculating fungi in modified 
casein hydrolysis medium. After inoculation cultures are incubated at 25°C for 7 
days. Degradation of milk protein can be measured as depth of clear zone (in mm).  
b) Lipolytic activity
22
: Test fungi are inoculated onto Ullman and Blasins 
media. After incubation at 25°C for 7 days, the lipolytic ability is observed as a 
visible precipitate due to the formation of crystals of calcium salt of the oleic acid 
liberated by the enzyme. The depth of precipitate (in mm) can be measured.  
c) Urease Activity
22
: Can be demonstrated by inoculation onto Christensen 
urea medium. After inoculation, cultures are incubated at 25°C for 3-5 days. 
Appearance of a deep pink color indicates a positive test. 
d) Hemolytic Activity
23
: Can be demonstrated by growing the fungal 
colonies on Sabouraud Dextrose agar with 7% sheep blood and Gentamicin. 
Appearance of a clear zone of hemolysis surrounding the fungal growth following 
incubation indicates production of hemolysin which is an important virulence 
factor responsible for spread of fungal infections. 
d) Screening for aflatoxin production:
22,23
 Aflatoxin can be extracted 
from the cultured fungi using solvents like chloroform or methanol. Aflatoxins can 
be detected by ELISA or high performance liquid chromatographic method 
(HPLC).  Extracted mycotoxins can be visualised under UV light (254 or 365 nm). 
Aflatoxins B and G when present fluoresce blue and greenish blue respectively. 
The intensity of the fluorescence is compared with that of the standard 
aflatoxins
61,62
.  
e) Biofilm Formation:
64,120
 Formation of  Biofilm is one of the most 
important virulence factors of Candida species. Yeast cells can detach from the 
adherent biofilms causing dissemination of fungi, with development of serious 
systemic infections. Biofilm forming Candida are resistant to antifungal treatment. 
Biofilms play a major role in persistence of fungal infections not responding to 
therapy 
64
. 
 
Antifungal susceptibility testing: 
With the increase in incidence of fungal infections and the rising number of 
antifungal drugs, laboratory methods to guide the selection of antifungal therapy 
are the need of the hour.  
A disk diffusion method for testing Candida species has been developed 
and published as CLSI document M44A
66
. 
A Reference Method for Broth Dilution Antifungal Susceptibility Testing 
of Filamentous Fungi was developed and published as CLSI document M38A 
67
. 
 
 
Antifungal Susceptibility Testing Methods: 
Antifungal susceptibility testing methods are available to detect antifungal 
resistance and to determine the best treatment for a specific fungus. It can be done 
by various methods: 
1.) Broth Microdilution Method66,67,68: CLSI document M27-A3 “Reference 
Method for Broth Dilution Antifungal Susceptibility Testing of Yeast; 
Approved Standard” is used for antifungal susceptibility testing of yeasts66.  
CLSI document M38-A2 “Reference Method for Broth Dilution 
Antifungal Susceptibility Testing of Filamentous Fungi; Approved 
Standard” is the currently acceptable standard for testing filamentous 
fungi
67
.  
Microdilution methods are the gold standard for antifungal 
susceptibility testing. Two organizations, the European Committee on 
Antibiotic Susceptibility Testing (EUCAST) and the Clinical Laboratory 
Standards Institute (CLSI) have standardized methods to perform 
antifungal susceptibility testing. But these methods are restricted to 
reference laboratories as they are laborious and expensive. 
2.) Broth macrodilution methods: These methods are also available for 
susceptibility testing of both yeasts and moulds. It is very cumbersome and 
not used much nowadays. 
3.) Disc Diffusion Method66: Disk diffusion tests on agar are inexpensive and 
easy to perform and serve as an ideal screening test. The disk diffusion 
method to test antifungals for yeasts (CLSI Standard: CLSI M44 A) has 
been developed and validated for species of Candida. It recommends the 
use of Mueller-Hinton agar supplemented with 2% glucose and 0.5 mg/L 
methylene blue dye medium which enhances the zone edge definition, 
thereby minimizing the trailing effect
63
. The pH of the medium should be 
between 7.2 and 7.4 with an agar depth of upto 4cm. The yeast inoculum is 
standardized to 0.5 McFarland and plates should be incubated at 35 ºC for 
24 hours.  
The standard disk diffusion test for non-dermatophyte filamentous 
fungi isolates (M51-A and supplement M51-S1) gives qualitative results in    
8-24 hours when amphotericin B, triazoles and caspofungin are used, faster 
than the Broth Microdilution Method. Among Aspergillus species, a lower 
agreement by disk diffusion susceptibility tests was observed with 
Aspergillus flavus and amphotericin B or voriconazole. Amphotericin B to 
test Aspergillus fumigatus susceptibility also showed a lower agreement 
when compared to the reference microdilution method
70
.  
Though qualitative results provided by the disk diffusion method are 
useful in the routine clinical laboratory, quantitative MIC data provides a 
more accurate method for identifying susceptible and resistant strains. 
4.) E Test: It is a commercially prepared plastic strip which contains 
predefined gradient of antifungal drug concentrations. This method can be 
used for routine antifungal susceptibility testing of isolates but not 
recommended for categorisation of resistant strains 
53,71,72,73
. 
5.) Automated Methods53: Several automated or semiautomated commercial 
methods based on agar diffusion or colorimetric indicators as in Etest, 
Sensititre Yeast One, Fungitest or Vitek are available. Automated systems 
significantly reduce the biologist hands-on time, turnaround time, and 
variability due to the standardized format. However these methods have to 
be evaluated with reference methods to determine breakpoint agreement 
cutoffs. 
6.) Newer methods: 53  
 Flow Cytometry: By Flow Cytometry, the effects of a given 
antifungal drug can be detected by observing alterations in the fungal 
cell viability (rather than the growth inhibition as in conventional 
methods) causing changes in the measured cell fluorescence. 
 Matrix Assisted Laser Desorption Ionisation – Time of Flight 
(MALDI-TOF): Using MALDI-TOF MS, a simple and rapid AntiFungal 
Susceptibility Test (named MS-AFST) was established to identify 
susceptible and resistant isolates.  
 Isothermal Micro Calorimetry (IMC) : IMC was establshed for  
susceptibility testing of Aspergillus species in Real Time , by measuring 
thermal variations induced by the action of antifungals and expressed as 
minimal heat inhibitory concentration (MHIC).  
Molecular Diagnosis: 
1) Polymerase Chain Reaction (PCR)74,75,76,99: It is a primer initiated, 
enzymatic amplification of specific DNA sequence. It has 3 steps: 
 Extraction of DNA: 
  Amplification: There are 4 phases in amplification. 
a) Initial Denaturation.  
b) Denaturation. 
c) Annealing. 
d) Extension. 
 Electrophoresis:  
2) Gene Sequencing76,77: 
Sequencing of the ribosomal DNA is a useful diagnostic tool for the 
rapid detection and identiﬁcation of fungi. In addition to speciation it also 
helps in detecting genes responsible for virulence and drug resistance
78
. 
One of the most common ribosomal targets for sequencing is the Internal 
Transcribed Spacer (ITS) region of the rDNA
79
. This region has two 
regions, ITS1 and ITS2, located between the 18S and 28S ribosomal 
subunits and separated by the 5.8S ribosomal subunit. The amplicon is 
usually 400 to 700 bp in length. D1/D2region is a second variable region 
within the ribosomal DNA (rDNA) cluster, which can also be ampliﬁed. 
The D1/D2 region is located toward the 5‟ end of the ribosomal subunit 
(26S or 28S). The conserved sequences at the ends of the D1/D2 and ITS 
regions provide universal PCR priming sites, while the variable internal 
regions provide species-speciﬁc sequences for identification.  
Sequence analysis: The sequence data are assembled and analyzed 
by the use of Sequence analysis software. Individual nucleotide-nucleotide 
searches are done with the BLASTn algorithm at the NCBI website 
(http://www.ncbi.nlm.nih.gov/BLAST/). The outputs from the BLAST 
searches are sorted on the basis of the maximum identity and recorded as 
they appear. Sequence-based identities with a cutoff of 97% or greater are 
considered signiﬁcant, and the best hit is deﬁned as the sequence with the 
highest maximum identity to the query sequence. 
Treatment Of Otomycosis
2,6,7
: 
1. The first step in treatment is identification and elimination of existing 
predisposing factors.  
2.  Cleaning and thorough debridement of external auditory canal is done 
preferably by suction evacuation . 
3.  Syringing of external auditory canal should be avoided as it may 
sometimes lead to flare up of the infection to deeper anatomical sites. 
Syringing if done, should be done under strict aseptic conditions using 
normal saline mixed with antifungal powder. 
4. Topical Therapy: Topical antifungals like Clotrimazole cream, powder 
or solution (1%), Amphotericin B (3%), Econazole cream (1%) and 
Flucytosine (10%) can be used. Nystatin cream, ointment or powder, 
Ketoconazole, Fluconazole, Miconazole 2% cream, thiomersal 
(Merthiolate) or Cresyl acetate solution can also be used. Clotrimazole 
has an antibacterial effect, and this is an added advantage when treating 
mixed bacterial-fungal infections
52
. In case of perforated tympanic 
membrane, Tolnaftate 1% solution (Tinactin) is preferred. 
5. Systemic antifungal therapy2: Systemic antifungal therapy is required 
only in cases of failure with topical therapy, invasive external otitis or 
in immunocompromised patients. Oral Itraconazole can be used for 
superficial otitis externa not responding to topical clotrimazole 
therapy
81
. Systemic Amphotericin B has also been used in invasive 
otitis externa. Voriconazole is used for treatment of invasive otitis 
externa including perforation of the tympanic membrane. 
6. Tympanoplasty might be needed if the perforations do not heal 
spontaneously
37
. 
Efficacy of Clotrimazole and miconazole topical applications have been 
proven  in the treatment of otomycosis 
52,80,82,83,84
.  
 
Antifungal Resistance:   
 
Despite increase in the spectrum of antifungal agents now available, the 
choice of suitable antifungal agents may be limited due to various factors like 
emergence of resistant fungal species
85
. Antifungal resistance can be primary 
(intrinsic) or secondary (acquired).  
Acquired Itraconazole resistance in Aspergillus fumigatus and Aspergillus 
niger have been described in isolates causing otomycosis
86,87
. Such  isolates may 
also be resistant to econazole. Some isolates may be resistant to voriconazole and 
posaconazole
88,89,90 
. 
Innately Resistant Fungi
18,53
:  
Among filamentous fungi, members of the order Mucorales are usually not 
susceptible to Echinocandins. Fusarium is resistant to Itraconazole and 
Echinocandins, it requires treatment with high dose Amphotericin B or 
Voriconazole. Pseudallescheria and Scedosporium are resistant to Amphotericin 
B even at high concentrations. Aspergillus terreus is resistant to Amphotericin B 
both in vitro and in vivo. 
Among yeasts, Candida krusei is multidrug resistant, with decreased 
susceptibility to Fluconazole, Amphotericin B and Flucytosine. Candida glabrata 
is less susceptible to Amphotericin B and Fluconazole
91
.  
According to studies by, resistance rates among Candida albicans isolates 
for amphotericin B, fluconazole , flucytosine , itraconazole , voriconazole  were 
2.9%, 5.9%, 0.0%, 4.2% and 2.5%, respectively. 
  
MATERIALS AND METHODOLOGY 
 This study was conducted at the Government Kipauk Medical College for a 
period of one year from January 2016 to December 2016. 
 Patients attending the ENT department with symptoms of Otomycosis were 
selected as the study population. 
Study Design: Cross Sectional Descriptive study 
Duration of Study: 1 year (Jan 2016 to Dec 2016)  
Statistical Analysis:   
 Statistical analysis was done using SPSS software 16.0 version. Chi square 
test was used to test association and p value was calculated. A p value of 
0.05 or less was considered significant.  
Inclusion criteria:     
 Both male and female patients of all age groups  with clinically suspected 
otomycosis attending the ENT OPD  
 All clinically diagnosed and untreated cases of otomycosis were included in 
the study.                              
Exclusion criteria: 
 Bacterial cause of otitis externa. 
 Patients with otomycosis on  antifungal treatment.  
Ethical committee approval: Approval was obtained from the Instituitional 
Ethical Committee before starting the study on 22.12.2015. 
 Patients with clinically suspected otomycosis were identified. Consent for 
the study was obtained. 
 History of otalgia, aural pruritis, ear discharge, diminished hearing, ear 
block, and tinnitus was elicited. History of any predisposing factors like 
habitual cleaning with unsterile materials, swimming, instillation of oil in 
ear, previous ear infections, ear surgery or trauma and diabetes mellitus 
was also elicited. 
  Under strict aseptic precautions the debris in the external auditory canal 
was collected using 3 sterile swabs, after cleaning the pinna and adjacent 
areas with antiseptic solution. A repeat swab was taken on the same day 
after 2 hours to rule out contamination. 
 The collected specimen was sent to the lab promptly along with a proper 
requisition slip and processed within 30 minutes. 
Direct Microscopy With 10% Pottasium Hydroxide Mount
2,53 
 The specimen was placed in 1- 2 drops of 10% KOH on a clean glass slide. 
 A clean and thin cover slip was placed over the preparation without any air 
bubbles. 
 The slide may be gently heated to clear the debris. 
 The preparation was examined using 10x and 40x magnification of a bright 
field microscope. 
 Presence of fungal elements (hyphal elements, Conidiophore, spores) was 
looked for. 
Fungal Culture
2,53
: 
 The specimen was inoculated onto Sabouraud‟s dextrose agar slopes in 
duplicate. Cycloheximide / Actidione was not added to the Sabouraud‟s 
dextrose medium, as they inhibit growth of saprophytes.  Gentamicin 50mg 
was added to one litre of SDA to minimize bacterial contamination. 
 All inoculated media were incubated at 25°C and were observed daily for 
upto 4 weeks to look for fungal growth. 
 Macroscopic features of the fungus like surface, texture, pigmentation on 
obverse and reverse, rate of growth were noted. 
 The fungal growth was then subjected to microscopic examination using 
LPCB. 
 An alcohol – sand flask was used to remove excess fungal material from 
the needle. The sand flask was made by placing 200 ml of coarse, washed 
sand into a 250 ml flask and filling it nearly to the top with 95% ethanol. It 
was kept closed with a lid to prevent evaporation. Excess fungal material in 
the needle can be removed by vigorously agitating it in the sand bath before 
flaming it. 
Lactophenol cotton blue mount (Wet mount)
53,55
: 
 A drop of lacto phenol cotton blue was placed in the centre of a clean glass 
slide. A small portion of the fungal growth was kept on it and teased using 
teasing needle.  
 A thin, clean cover slip was applied over it, without any air bubbles.  
  It was then viewed using light microscope first under low power and then 
under high power objective for identifying microscopic morphological 
features, 
 Slide culture was done wherever necessary. 
Riddle’s Slide Culture53    
  A sterile Petri dish labelled with the patient identification and date of 
inoculation was taken.  
 A sterile V or U shaped glass rod was placed inside the petridish over 
which a sterile grease free glass slide was kept. 
 Sabouraud dextrose agar or Potato dextrose agar was poured to a depth of 
4mm in a sterile petridish. 
 1×1 cm block of the agar was cut and transferred aseptically onto the sterile 
glass slide. 
 From the fungal growth the four sides of the agar block were inoculated. A 
sterile glass cover slip was placed over the agar block. 
 A small amount of distilled water was placed inside the Petri dish to keep 
the atmosphere humid.  
 The plate was then incubated at 27°C till adequate growth of the fungus 
was obtained.  
 When spores were well developed, the coverslip was removed with a 
forceps and placed onto a drop of lactophenol cotton blue on a second slide. 
 A second preparation was made by removing the agar block from the slide 
culture and doing a lacto phenol cotton blue preparation on the slide. 
 The microscopic morphological features like hyphae, Conidiophores and 
Conidia were noted using low power and then high power magnification of 
the microscope.  
Banana Peel Cuture
57
: 
 Ripe banana peel was taken and cut into small squares of approximately 
2cms. 
 The peel was sterilized by autoclaving twice at 121°C, 15 lbs for 15 min 
on two consecutive days. 
 The sterile peels were placed flat in a sterile glass petridish. 
 The fungal growth was inoculated onto the peel. A sterile, glass 
coverslip was placed over the peel.  
 Few drops of sterile water was left inside the petridish to provide 
moisture. 
 The plates were incubated at 25°C, for 3-5 days till sufficient growth of 
fungus was observed. 
 Once the spores were well developed, the coverslip with the adherent 
fungal growth was gently lifted with a forceps and placed onto a sterile 
glass slide with a drop of lactophenol cotton blue. 
 The undistorted microscopic morphology was observed under low and 
high power objectives and the fungus was identified. 
IDENTIFICATION OF YEASTS:
53,55,92,93
 
 If the growth was opaque, creamy white, Grams staining was done. 
 If gram positive budding cells were seen Candida was identified.  
 It was further speciated by Germ tube test, Urease test, Sugar 
Fermentation test, Sugar Assimilation test, Chlamydospore formation 
on Corn Meal Agar and colour of colonies on CHROM agar. 
Germ Tube Test (Reynolds Braude phenomenon):
55
 
Growth from the yeast colonies was suspended in 0.5 – 1 ml of human 
serum and incubated at 37°C for 2- 3 hours.  
A drop of the suspension was kept on a slide and examined microscopically 
for the presence or absence of germ tubes.  The germ tube can be seen as a long 
tube like projections arising directly from the yeast cell having parallel walls, 
without any constriction at their point of origin. 
Germ tube positive colonies were tested for formation of germ tubes after 
incubation at 42°C to differentiate Candida albicans from Candida dublinensis. 
Colour of colonies on CHROM agar:
58,94,95,96,97
 
 Using sterile loop the yeast colony was inoculated onto CHROM agar 
plate. 
 The plates were incubated at 25°C for 3 – 5 days. 
 The colour of the colonies were noted. 
Chlamydospore Formation on Corn Meal Agar (Dalmau Plate Technique)
92
 
 The Corn Meal Agar plate was divided into 4 quadrants and labelled. Using 
a sterile straight needle, the yeast colony was touched lightly and 2 -3 
streaks of approximately 4 cm long and 1 – 2 cms apart were made. A 
flame sterilized and cooled 22mm square cover slip was placed over the 
streaks. 
 The plates were incubated at 25°C for 3 – 5 days. 
 The lid of the petri plate was removed and the plate was placed on the 
microscopic stage. The edge of the cover slip was observed using low 
power and high power objective. 
 Morphological features like pseudohyphae and chlamydospores were 
noted. 
 
Sugar Fermentation Test:
92
 
 Sugar fermentation medium containing different sugars like dextrose, 
lactose, maltose, sucrose in a concentration of 2% were taken, in test 
tubes. Inverted Durham‟s tube was placed to note the collection of gas. 
 Inoculum preparation was done by suspending a heavy inoculum of the 
yeast grown on sugar free medium. The test tubes were inoculated by 
adding 0.1ml of the Candida suspension.   
 The sugar tubes were incubated for upto a week at 25°C.  
 If the sugar was fermented the colour of medium was changed to yellow. 
Sugar Assimilation Test:
92
 
• A heavy inoculum of a 24 – 48 hrs old yeast culture was suspended in 2 ml 
of Yeast Nitrogen Base. The suspension was then added to 18 ml of molten 
agar (cooled to 45° C) and mixed well. The entire volume was poured into 
90 mm petri plate and allowed to solidify. 
• The carbohydrate impregnated discs were placed onto the agar surface and 
the plates were incubated at 37 °C for 3 – 4 days. Presence of growth 
around the disc was considered as positive for that particular carbohydrate. 
Growth around the glucose disc serves as positive control for viability of 
the yeast.  
  
TESTS FOR VIRULENCE: 
Urease Activity
22
 
 Using a sterile loop, yeast colony or mould colony was inoculated onto 
Christensen urea medium and incubated at 25°C for 3-5 days.  
 Appearance of a deep pink color indicates a positive test. 
 
Hemolysin production
23
 
 Colonies of Aspergillus species were inoculated onto Blood agar plate 
containing 7% sheep blood mixed in Sabouraud Dextrose Agar. 
 The plates were incubated at 25°C for 3-5 days. 
 Appearance of hemolysis surrounding the fungal growth indicates a 
positive test. 
Biofilm formation
64,120
: 
 Using sterile loop, Candida colonies from a 18 -24 hours culture on SDA 
was taken. 
 It was inoculated into 5ml of Sabouraud‟s Dextrose broth and the turbidity 
was adjusted to o.5 Mac Farland standard. 
 The tubes were incubated at 37°C for 18 - 24 hours. 
 The broth was poured out and washed with Phosphate Buffer Saline. 
 0.5% crystal violet solution was added and stained for 10 minutes. 
 A visible and uniform violet coloured film in the tube indicates presence of 
biofilm. 
Toxicity Testing for Aflatoxin by High Performance Liquid 
Chromatography (HPLC)
26,27
:  
• Fungus to be tested was cultured on Sabouraud‟s Dextrose Agar slope 
• 50 gms of the test portion was transferred into a 500 ml Erlenmeyer flask 
and 5gms of NaCl was added. 
• The test portion was extracted with 300 ml methanol extraction solvent  
and 100 ml hexane in  a blender at high speed for 3 minutes. 
• The extract was filtered through a fluted filter paper. 
• 10 ml of clear filtrate was added to 60 ml of Phosphate buffered saline 
(PBS) and applied to the affinity column containing antibodies to aflatoxins 
B1, B2, G1 and G2. 
• 10 ml of the PBS solution with the filtrate was applied to the top of the 
column and allowed to pass at a speed of 2-3ml/min through the column by 
gravity. 
• Aflatoxins were eluted from the column with 0.5ml methanol. 
• Post column derivatization was done using pyridinium hydrobromide 
perbromide (PBPB). 
• 200 mL of aflatoxin standards were eluted through the liquid 
chromatograph. Aflatoxins elute in the order G2, G1, B2, and B1 with 
retention times of 6, 8, 9, and 11 min respectively. 
•  200 mL of the test extract was injected into the injector and each aflatoxin 
peak and retention times in the chromatogram was identified and compared 
with the corresponding reference standard by fluorescence detection. 
Quantity of each aflatoxin was also derived from the standard curve.  
 
ANTIFUNGAL SUSCEPTIBILITY TESTING: 
MICROBROTH DILUTION METHOD FOR FILAMENTOUS FUNGI
67
: 
Inoculum Preparation
67
  
 Moulds: The fungi was subcultured on Potato Dextrose Agar tubes and 
incubated at 25°C for 7 days. Using a sterile Pasteur pipette the surface of 
colony was gently washed with 3 ml sterile distilled water or saline. The 
suspension was allowed to stand for few minutes so that larger hyphal 
segments settle. The suspension was vortexed . Then the top homogenous 
layer was used to obtain desired inoculum density. 
 Inoculum was adjusted using spectrophotometer with test inoculums in 
range 0.4×10
4 
to 5× 10
4 
CFU/ml. Optical density was  measured at 530nm 
 For Aspergillus and Sporothrix OD – 0.09 -0.11 
 For  Fusarium, Rhizopus and Scedosporium OD – 0.15 – 0.17 
 For Bipolaris and Histoplasma  OD – 0.2 
 100µl of conidial suspension was added to 4.9ml RPMI (1:50 dilution) to 
get a viable conidial concentration of approx.0.4×10000 to 5×10000 
CFU/ml 
 RPMI 1640 medium supplemented with 0.2% glucose buffered to pH 7 was 
used. 
 The following drug concentration ranges were used: Amphotericin B, 
0.0313 to 16 µg/mL; Ketoconazole, 0.0313 to 16 µg/mL; Itraconazole, 
0.0313 to 16 µg/mL; Fluconazole, 0.125 to 64 µg/mL; and new triazoles, 
0.0313 to 16 µg/mL.  
 Microdilution plates were incubated at 35°C and read at 24 hrs for 
Rhizopus and at 48 hours for Aspergillus , Fusarium and Sporothrix ; 78 
hours for Scedosporium.  
  Microdilution wells were visualised with reading mirror and growth 
compared to drug free growth control. 
 Score :0 – Optically clear  
1 – Slight growth (25 % of growth control) 
2 – Prominent reduction in growth (50 % of growth control) 
3 – Slight reduction in growth (75 % of growth control) 
4 –No reduction in growth  
• For Amphotericin B, newer azoles like Voriconazole, Itraconazole, 
Posaconazole, MIC = Score 0 
• For Flucytosine , Fluconazole MIC = Score 2 
Fungal isolates were considered susceptible to Amphotericin B, 
Itraconazole, Posaconazole, Voriconazole, and Caspofungin when the MIC/MEC 
was ≤1.0 mg/ml, intermediate when MIC/MEC was 2.0 mg/ml, and resistant when 
the MIC/MEC was ≥ 4.0 mg/ml. 
Dose of Antifungal: 
Weight (mg) = Volume (mL) X Concentration (µg/ML) /Assay Potency (µg/mg)  
 
MIC Breakpoints: 
Antifungal 
Agent 
End Point Sensitive 
(MIC) 
Intermediate 
(MIC) 
Resistant 
(MIC) 
Amphotericin B 100%  reduction in growth 
compared to the growth in 
the control well 
≤1μg/mL 2 μg/mL ≥ 4 μg/mL 
Fluconazole 50% or more  reduction in 
growth compared to the 
growth in the control well 
≤1 μg/mL 2 μg/mL ≥ 4 μg/mL 
Clotrimoxazole 100% or more  reduction 
in growth compared to the 
growth in the control well 
≤1 μg/mL 2 μg/mL ≥ 4 μg/mL 
Itraconazole 100%  reduction in growth 
compared to the growth in 
the control well 
≤1 μg/mL 2 μg/mL ≥ 4 μg/mL 
Voriconazole 100%  reduction in growth 
compared to the growth in 
the control well 
≤1 μg/mL 2 μg/mL ≥ 4 μg/mL 
 
 
DISC DIFFUSION TEST FOR YEASTS
66
: 
 Antifungal sensitivity was done by disc diffusion test according to CLSI 
M27A2 for yeasts. 
 Done on Mueller-Hinton Agar + 2% Glucose and 0.5 µg/mL Methylene 
Blue Dye (GMB) Medium with a pH of 7.2 – 7.4 
 Preparation of the inoculum 
 The Candida colonies were subcultured  on Sabouraud „s dextrose 
agar and incubated at 35 °C (±2 °C). 
 Inoculum was prepared by picking five distinct colonies of 
approximately 1 mm in diameter from a 24-hour-old culture of 
Candida species. Colonies were suspended in 5 mL of sterile 0.85%  
saline.   
 The resulting suspension was vortexed for 15 seconds and its turbidity 
was adjusted to 0.5 McFarland standard. 
 This procedure will yield a yeast stock suspension of 1 x 106 to 5 x 
10
6
 cells per mL. 
 Inoculation and Reading of Test Plates: 
1. Within 15 minutes after adjusting the turbidity of the inoculum 
suspension, a sterile cotton swab was dipped into the suspension. The 
swab should be rotated several times and pressed firmly against the 
inside wall of the tube above the fluid level. This will remove excess 
fluid from the swab. 
2. The dried surface of a sterile Mueller-Hinton + Glucose Methylene 
Blue agar plate was inoculated by evenly streaking the swab over the 
entire agar surface. This procedure was repeated by streaking two 
more times, rotating the plate approximately 60° each time to ensure 
an even distribution of inoculum. As a final step, the rim of the agar 
was swabbed. 
3.  Antimicrobial disks were dispensed onto the surface of the inoculated 
agar plate. 
4. The plates were inverted and placed in an incubator set to 35°C (± 
2°C) within 15 minutes after the disks are applied.   
5. Sensitivity was tested for AmphotericinB, Clotrimoxazole, 
Fluconazole, Itraconazole and Voriconazole. 
6. The plates were read after 20 to 24 hours of incubation.  
7. The zone diameter was measured to the nearest whole millimeter at 
the point at which there was prominent reduction in growth.  
Interpretation of Disk Diffusion Test Results: 
 
Drug 
 
Potency 
Zone Diameter in mm 
S I R 
Clotrimazole 10 μg ≥19 18-12 ≤11 
Amphotericin B 10 μg ≥15 14-10 ≤10 
Voriconazole 1 μg ≥17 16-14(DD) ≤13 
Itraconazole 8 μg ≥15 14-10(DD) <10 
Fluconazole 25 μg ≥19 18-15(DD ≤14 
 
  
MOLECULAR DIAGNOSIS: 
Extraction of DNA: 
1.) 500 µl TESS buffer + 1 loop of colony was added to aliquots in duplicate 
and boiled for 1 minute.  
2.) 500 µl Phenol and 500 µl chloroform were added in the ratio 1:1 and 
vortexed. 
3.) Centrifuge was done at 10000 rpm for 10 minutes 
4.) The top aqueous layer was pipette. 
5.) Equal volume of chloroform was added to remove traces of phenol present 
and mixed well 
6.) Centrifuge was done at 10000rpm for 10 minutes. 
7.) The top aqueous layer which containing the nucleic acid was pipette. 
8.) Equal volume of isopropyl alcohol was added to precipitate the nucleic 
acid. 
9.) The supernatant was discarded.  
10.) Nucleic acid forms a pellet at the bottom of the tube. 
11.)  200 µl of 70% ethanol was added and centrifuged at 10000rpm for 10 
minutes 
12.) The supernatant was discarded and air dried for 20 minutes. 
13.)  40 µl nuclease free water was added. 
 
Polymerase Chain Reaction (PCR)
75,76,98,99
: 
1.) In a 0.2ml sterile PCR tube, 5 µl Enzyme buffer, 1 µl dNTPs, 0.5 µl 
Forward primer (ITS 1- 5′-GATACCGTCGTAGTCTTA-3′), 0.5ml 
Reverse primer (ITS 4- 5′-ATTCCTCGTTGAAGAGC-3′), 42.7 µl sterile 
nuclease free water, 0.3µl Taq polymerase and 5 µl template DNA were 
added. 
2.) The tubes were placed in a thermocycler and PCR was performed. 
Step Temperature (°C) Time 
Initial denaturation 94  5min 
Denaturation 94  30 seconds 
Annealing 52 2 minutes 
Extension 72 1 minute 
Final extension 72 7 minutes 
  
3.) Cycling was done for 30 cycles. 
Electrophoresis:  
1. Both ends of the gel tray were sealed with cellophane tape 
2. 2g of agarose was dissolved in 100 ml buffer 
3. The solution was microwaved for 2 minutes and cooled to 50°C 
4. 1 µl ethidium bromide was added, mixed and poured into gel tray. 
5. Combs were placed in appropriate position and the gel was allowed to set. 
6. The gel was then placed in electrophoresis tank  
7. Buffer was added to cover the gel upto 2 mm 
8. 10 µl of DNA sample was mixed with 2 µl gel loading buffer and loaded 
into the lane. 
9. 1 µl of DNA molecular weight marker, 4 µl water and 1 µl gel loading 
buffer were mixed and loaded into another lane 
10. The tank lid was closed and current was applied at 1 to 5 volt/cm 
11. The bands were then visualised under UV light. Pan fungal DNA is 
measured at 270 bp. 
Gene Sequencing
77
: 
The PCR products were purified with a Qiagen PCR purification kit. Both 
strands were sequenced by Sanger‟s dideoxynucleotide sequencing method. The 
sequences were obtained as overlapping runs of the two flanking primers (primers 
ITS-1 & NL-4), as well as runs of two internal primers (primers ITS-4 and NL-1).  
Sequence analysis:  
The sequence data were assembled and analyzed by the use of Sequence 
analysis software. Individual nucleotide-nucleotide searches are done with the 
BLASTn algorithm at the NCBI website(http://www.ncbi.nlm.nih.gov/BLAST/). 
The outputs from the BLAST searches are sorted on the basis of the maximum 
identity and were recorded as they appeared without modiﬁcation of genus or 
species names that may have been synonyms or teleomorphs of other genus or 
species names in other GenBank records. Sequence-based identities with a cutoff 
of 97% or greater were considered signiﬁcant in this study, and the best hit was 
deﬁned as the sequence with the highest maximum identity to the query sequence. 
 STATISTICAL ANALYSIS   
The outcome of this study was noted, documented and analysed. The 
analysed data was presented in the form of statistical tables and represented as pie 
charts, bar diagrams or histograms wherever necessary. The p-values were 
calculated by Chi –Square test to compare the proportion between categorical 
variables. If expected cell frequency was less than five in more than 20% of cells, 
Fisher‟s exact Chi –Square test was applied. SPSS (Stastical package for the social 
science) version 22.0 was used to analyse the data. Significance level was fixed as 
5% (α=0.005) with a p value of <0.05.The observationsof this study was 
compared and discussed with similar studies published in reputed scientific 
journals for simlarities and contrasts in the results. 
  
RESULTS 
This study was carried out in the department of Microbiology, Government 
Kilpauk Medical College, over a period of 12 months from January 2016 to 
December 2016. The results were analyzed as follows. 
CHART 1 
 
200 cases of clinically suspected otomycosis were analysed out of which 
105 samples showed growth of fungi, accounting for 52.5%.  
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FUNGAL CULTURE POSITIVITY IN 
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CHART 2  
 
 
Fungus was isolated from all age groups ranging from 1 year to >60years 
of age. Maximum number of cases were observed in the age group 21-30 years 
with 27 cases (25.71%) followed by 31 – 40 years with 25 cases (23.81%) which 
showed a significant statistical p value of <0.001. Least number of cases were in 
the age group 1-10 years with 2 cases (1.9%). 
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CHART 3 
 
Among the positive samples 62 were from females accounting for 59% and 
43were from males with 41%. The female: male ratio was 1.44:1. 
CHART 4 
 
Otomycosis was unilateral in 101 cases (96%) and Bilateral in 4 cases (4%) 
with a significant value of p <0.001.  
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Habitual cleaning of ears using unsterile materials like ear buds, safety 
pins, match sticks was the common predisposing factor seen in 73 cases (70%). It 
was found to be statistically significant with a p value of <0.001. Use of ear drops 
was observed in 41 cases (39%) while Oil instillation in ears was noted in 32 cases 
(31%). Diabetes mellitus as a comorbid factor was noted in 17 patients (16%). 
 
CHART 6 
 
The presenting symptoms in decreasing order were Aural pruritis-89 
(85%), Ear block/ Fullness of ear – 73(70%), Otalgia- 50 (48%), Diminished 
hearing – 41(39%), Ear discharge – 37(35%) and Tinnitus- 6 (6%). The p value by 
Pearson Chi Square was found to be <0.001 which was significant. 
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OF the 105 culture positives, 101 were KOH positive. The analysis was 
significant with a p value of <0.001. The parameters derived using statistical 
analysis for diagnosis by culture were. 
Parameter Estimate (%) Lower – Upper 95% 
CIs 
Sensitivity 100.0 96.34 – 100.0 
Specificity 95.96 90.07 – 98.42 
Positive Predictive Value 96.19 90.61 – 98.51 
Negative Predictive Value 100.0 96.11 – 100.0 
Diagnostic Accuracy 98.00 94.97 – 99.22 
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Out of the 105 fungi isolated, 81 were filamentous fungi (77%) and 24 
were Candida species (23%). The p value was significant with <0.001. 
 
 
 
 
 
 
 
 
 
TABLE 1 
TABLE OF DIFFERENT SPECIES ISOLATED IN THE STUDY (n=105) 
FUNGUS ISOLATED  NUMBER  PERCENTAGE  
FILAMENTOUS FUNGI (n=81) 
Aspergillus niger  51 49% 
Aspergillus flavus  14 13% 
Aspergillus terreus  4 4% 
Aspergillus fumigatus  2 2% 
Rhizopus oryzae 2 2% 
Cladosporium cladosporoides 2 2% 
Aspergillus nidulans  1 1% 
Aureobasidium pullulans 1 1% 
Fonsaceae pedrosoi 1 1% 
Rhizomucor pusillus 1 1% 
Mucor circinelloides 1 1% 
Curvularia lunata 1 1% 
NON FILAMENTOUS FUNGI (n=24) 
Candida albicans 20 19% 
Candida parapsilosis 2 2% 
Candida glabrata 1 1% 
Candida krusei  1 1% 
Among the fungal species identified, Aspergillus niger was the most 
common isolate in 51 cultures (49%), followed by Aspergillus flavus in 14 
cultures (13%). Aspergillus terreus was isolated in 4 cultures. There were 2 
isolates each of Aspergillus fumigatus and Rhizopus. The rare causative fungi 
isolated were Cladosporium (2), Aspergillus nidulans (1), Mucor (1), 
Aureobasidium pullulans(1), Fonsaceae pedrosoi (1), Curvularia lunata (1) and 
Rhizomucor (1).  
Of the 24 Candida species isolated, 20 were Candida albicans, 2 were 
Candida parapsilosis, 1 was Candida glabrata and 1 isolate was Candida krusei.  
The results were statistically significant with a p value of <0.001 
 
 
 
 
 
 
 
 
 
TESTS FOR IDENTIFICATION OF CANDIDA SPECIES 
TABLE 2: GERM TUBE TEST (n=24) 
 
CANDIDA SPECIES 
GERM TUBE TEST 
POSITIVE 
GERM TUBE TEST 
NEGATIVE 
Candida albicans (n=20) 20 0 
Candida parapsilosis (n=2) 0 2 
Candida glabrata (n=1) 0 1 
Candida krusei (n=1) 0 1 
 
Of the 24 Candida isolates, 20 were Germ Tube Test positive and 4 were 
negative 
TABLE 3: CHARACTERSTICS ON CHROMAGAR (n=24) 
CHARACTERSTICS ON 
CHROMAGAR  
NUMBER PERCENTAGE 
ORGANISM 
IDENTIFIED 
Apple green colonies  20 83.33% Candida albicans 
White to pale pink  2 8.3% Candida parapsilosis 
White, large, glossy, pale 
pink to violet  
1 4.2% Candida glabrata 
Large, flat, spreading, pale 
pink colonies with matt 
surface  
1 4.2% Candida krusei 
 
Based on the colour of colonies on CHROMagar, 20 isolates of Candida 
albicans, 2 isolates of Candida parapsilosis, 1 isolate of Candida glabrata and 1 
isolate of Candida krusei were identified . 
TABLE 4: MORPHOLOGY ON CORN MEAL AGAR (N=24) 
MORPHOLOGY ON CORN 
MEAL AGAR 
NUMBER PERCENTAGE 
ORGANISM 
IDENTIFIED 
Abundant pseudohyphae. 
Budding cells, spherical 
chlamydospores mostly terminal 
often on a swollen subtending 
cell. 
20 83.33% Candida albicans 
Clusters of blastospores with 
occasional giant cells. 
2 8.3% 
Candida 
parapsilosis 
Pseudohyphae absent. Budding 
unipolar. Cells ellipsoidal, 
typically arranged in dense 
groups. Chlamydospore absent. 
1 4.2% Candida glabrata 
Branched pseudomycellium. 
Budding cells ellipsoidal to 
cylindrical. Cells liberated and 
arranged parallel to the main 
axis. 
1 4.2% Candida krusei 
 
Morphology and chlamydospore formation on Corn Meal agar by Dalmau 
technique was used to identify and speciate Candida isolates. 20 isolates of 
Candida albicans, 2 of Candida parapsilosis, 1 of Candida glabrata and 1 isolate 
of Candida krusei were identified. 
 
 
 
TABLE 5: SUGAR ASSIMILATION TEST FOR CANDIDA (n=24) 
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Candida 
albicans  
(n=20) 
20 
(100%) 
18 
(83%) 
0 
20 
(100%) 
20 
(75%) 
0 
19 
(92%) 
Candida 
parapsilosis 
(n=2) 
2 
(100%) 
1 
(50%) 
0 
1 
(50%) 
2 
(100%) 
0 
2 
(100%) 
Candida 
glabrata  
(n=1) 
1 
(100%) 
0 0 
1 
(100%) 
0 0 
1 
(100%) 
Candida 
krusei  (n=1) 
1(100%) 0 0 0 0 0 0 
 
On performing Sugar Assimilation test, all 20 isolates of Candida albicans 
assimilated glucose and maltose, 92% assimilated trehalose, 83% sucrose and 75% 
assimilated galactose. Both isolates of Candida parapsilosis assimilated glucose, 
galactose and trehalose while only 1 isolate assimilated sucrose and maltose. 
Candida glabrata assimilated glucose, maltose and trehalose. Candida krusei 
assimilated only glucose.  
 
 
TABLE 6: SUGAR FERMENTATION TEST FOR CANDIDA (n=24) 
SPECIES 
SUGAR FERMENTATION 
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Candida albicans  
(n=20) 
20 
(100%) 
0 0 
20 
(100%) 
18 
(75%) 
Candida parapsilosis 
(n=2) 
2 
(100%) 
0 0 0 0 
Candida glabrata  
(n=1) 
1 
(100%) 
0 0 0 
1 
(100%) 
Candida krusei  (n=1) 
1 
(100%) 
0 0 0 0 
 
All 20 Candida albicans isolates fermented glucose and maltose while 18 
fermented trehalose(75%). Candida parapsilosis was able to ferment only 
glucose. Candida glabrata fermented glucose and trehalose and Candida krusei 
fermented only glucose. 
 
 
 
 
VIRULENCE TEST FOR CANDIDA  
 
TABLE 7: BIOFILM FORMATION (n=24) 
CANDIDA SPECIES BIOFILM 
Candida albicans (n=20) 6 ( 29%) 
Candida parapsilosis (n=2) 1 (50%) 
Candida glabrata (n=1) 0 
Candida krusei (n=1) 0 
 
6 isolates of Candida albicans (29%) and 1 isolate of Candida parapsilosis 
were biofilm producers.  
 
 
 
 
 
 
 
 
VIRULENCE TESTS FOR ASPERGILLUS SPECIES  
TABLE 8: UREASE TEST 
Aspergillus species Number tested  Urease positive Percentage 
Aspergillus niger 51 0 0 
Aspergillus flavus 14 11 78.57% 
Aspergillus terreus 4 4 100% 
Aspergillus fumigatus 
2 0 0 
Aspergillus nidulans 1 0 0 
 
 Urease production was seen in 78.57% of the Aspergillus flavus isolates 
and all 4 Aspergillus terreus isolates. Urease production was not seen with 
Aspergillus niger, Aspergillus fumigatus and Aspergillus nidulans . 
TABLE 9: HEMOLYSIN PRODUCTION 
Aspergillus 
species 
Number tested 
Hemolysin 
positive 
Percentage 
Aspergillus niger 51 12 23.53% 
Aspergillus flavus 14 4 28.57% 
Aspergillus 
terreus 
4 3 75%% 
Aspergillus 
fumigates 
2 2 100 
Aspergillus 
nidulans 
1 0 0 
 
Hemolysin as a virulence factor was produced in 4 isolates of Aspergillus 
niger (7.8%), 2 isolates of Aspergillus flavus(1.4%), and 1 isolate of Aspergillus 
terreus (25%). 
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CHART -9 
 
TABLE 10: AFLATOXIN PRODUCTION BY HPLC 
 
 Aflatoxin B1 
(µg/kg) 
Aflatoxin G1 
(µg/kg) 
Aflatoxin B2 
(µg/kg) 
Aflatoxin G2 
(µg/kg) 
Aspergillus 
niger 1 
0.25 0.012 0.05 0.04 
Aspergillus 
niger 2 
0.26 0.23 0.05 0.08 
Aspergillus 
niger 3 
0.56 0.23 0.12 0.01 
Aspergillus 
niger 4 
0.36 0.18 0.03 0.08 
Aspergillus 
flavus 1 
0.05 0.01 0.23 0.45 
Aspergillus 
flavus 2 
0.12 0.12 0.56 0.08 
Aspergillus 
terreus 
0.12 0.05 0.23 0.08 
 
Aspergillus isolates producing hemolysin were tested for aflatoxin 
production by High Performance Liquid Chromatography (HPLC). All the isolates 
produced Aflatoxins. Higher production of Aflatoxins B1 and G1 was seen with 
Aspergillus niger while Aspergillus flavus and Aspergillus terreus produced more 
amounts of Aflatoxins B2 and G2. 
MOLECULAR METHODS 
TABLE 11: SPECIATION OF RARE FILAMENTOUS FUNGI:  
Number 
Isolated 
Pan Fungal 
PCR 
Gene Sequencing 
Species 
Identified 
2 POSITIVE 
AAATCTAAAACTAAGGAAGGCCCTATATCGGG
GGCATGCTGTTCGAGCGT 
CATTTCACCACTCAAGCCTCGCTTGGTATTGGG
CAACGCGGTCCGCCGCG 
TGCCTCAAATCGACCGGCTGGGTCTTCTGTCCC
CTAAGCGTTGTGGAAAC 
TATTCGCTAAAGGGTGCTCGGGGAGGCTACGC
CGTAAAACAAACCCATTT 
CTAAGGTTGACCTCGGATCAGGTAGGGATACC
CGCTGAACTTAAGCATAT 
CAATAAAGCGGGAGAAA 
Cladosporium 
cladosporoides 
 
2 of the rare isolates were subjected to PCR followed by Sanger 
sequencing. 270 bp Pan-fungal genome was identified and sequenced by Sanger‟s 
dideoxynucleotide sequencing method. Individual nucleotide-nucleotide searches 
were done with the BLASTn algorithm at the NCBI website. Sequence-based 
identities with a cutoff of 97% were obtained for both isolates and the fungi were 
identified as Cladosporidium cladosporoides. 
  
All the diagnosed cases were treated with Clotrimazole 1% ear drops or 
plugging of ear with Miconazole ointment applied in gauze. The patients were 
followed up at 1, 2, 4 weeks and 12 weeks. All the patients showed good response 
to treatment with negative culture by 2 weeks of treatment.  
From a microbiologists perspective, antifungal susceptibility to commonly 
used antifungal drugs was done to determine the Minimum Inhibitory 
Concentration (MIC) of the antifungal agents to the fungal isolates. 
  
ANTIFUNGAL SUSCEPTIBILTY PATTERN OF FILAMENTOUS 
FUNGI BY MICROBROTH DILUTION METHOD (CLSI M 38 A2) 
TABLE 12: MINIMUM INHIBITORY CONCENTRATIONS (MIC) FOR 
CLOTRIMAZOLE  
Drug  Clotrimazole Minimum Inhibitory Concentration (mg/ml ) 
FUNGI   n 0.03 0.0625 0.125 0.25 0.5 1.0 2.0 4.0 8.0 16 
A. niger  51 1 10 7 13 11 9 - - - - 
A. flavus  14 1 4 2 2 4 1 - - - - 
A. terreus  4 - - - 1 2 1 - - - - 
A. fumigatus  2 - - - - 1 1 - - - - 
Rhizopus 
oryzae 2 - - - - - 2 - - - - 
Cladosporium 
cladosporoides 2 - - - - 1 1 - - - - 
Aspergillus 
nidulans  1 - - - - - 1 - - - - 
Aureobasidium 
pullulans 1 - - 1 - -  
- - - - 
Fonsaceae 
pedrosoi 1 - - - - - 1 - - - - 
Rhizomucor 
pusillus 1 - - - - 1 - - - - - 
Mucor 
circinelloides 1 - - - -  1 - - - - 
Curvularia 
lunata 
1 - - - - 1  - - - - 
 
 
MIC of Clotrimazole to Aspergillus niger was in the range 0.03 – 1μg/ml. 
MIC50 was 0.25μg/ml and MIC90 was 1 μg/ml. For Aspergillus flavus the MIC 
range was 0.03 – 1 μg/ml. MIC 50 was 0.125 μg/ml and MIC90 was 0.5 μg/ml 
TABLE 13: MINIMUM INHIBITORY CONCENTRATIONS (MIC) FOR 
AMPHOTERICIN B  
 
MIC of Amphotericin B to Aspergillus niger was in the range 0.03 – 
1μg/ml. MIC 50 was 0.5μg/ml and MIC90 was 1 μg/ml. For Aspergillus flavus the 
MIC range was 0.0625 – 1 μg/ml. MIC 50 was 0.5 μg/ml and MIC90 was 1μg/ml. 
Drug  Amphotericin B Minimum Inhibitory Concentration  
(mg/ml ) 
FUNGI n 0.03 0.0625 0.125 0.25 0.5 1.0 2.0 4.0 8.0 16 
A. niger  51 2 2 3 11 24 9 - - - - 
A. flavus  14 - 1 1 1 7 4 - - - - 
A. terreus  2 - - - - 1 1 - - - - 
A. fumigatus  2 - - - - 1 1 - - - - 
Rhizopus 
oryzae 
2 - - - - 1 1 - - - - 
Cladosporium 
cladosporoides 
1 - - - - - 1 - - - - 
Aspergillus 
nidulans  
1 - - - - - 1 - - - - 
Aureobasidium 
pullulans 
1 - - - - - 1 - - - - 
Fonsaceae 
pedrosoi 
1 - - - - - 1 - - - - 
Rhizomucor 
pusillus 
1 - - - - 1 - - - - - 
Mucor 
circinelloides 
1 - - - - - 1 - - - - 
Curvularia 
lunata 
1 - - - - - 1 - - - - 
TABLE 14: MINIMUM INHIBITORY CONCENTRATIONS (MIC) 
FOR VORICONAZOLE  
DRUG  VORICONAZOLE MINIMUM INHIBITORY 
CONCENTRATION ( μg/ml ) 
FUNGI n 0.03 0.0625 0.125 0.25 0.5 1.0 2.0 4.0 8.0 16 
A. niger  51 1 3 19 12 11 5 - - - - 
A. flavus  14 1 1 1 6 3 2 - - - - 
A. terreus  4 - - 1 - 1 2 - - - - 
A. fumigatus  2 - - - - 1 1 - - - - 
Rhizopus 
oryzae 
2 - - - - 1 1 - - - - 
Cladosporium 
cladosporoides 
2 - - - 1 - 1 - - - - 
Aspergillus 
nidulans  
1 - - - - - 1 - - - - 
Aureobasidium 
pullulans 
1 - - - - 1 - - - - - 
Fonsaceae 
pedrosoi 
1 - - - - 1 - - - - - 
Rhizomucor 
pusillus 
1 - - - - - 1 - - - - 
Mucor 
circinelloides 
1 - - - - 1 - - - - - 
Curvularia 
lunata 
1 - - - - - 1 - - - - 
  
MIC of Voriconazole to Aspergillus niger was in the range 0.03 –1 μg/ml. 
MIC 50 was 0.25μg/ml and MIC90 was 0.5 μg/ml. For Aspergillus flavus the MIC 
range was 0.03 – 1 μg/ml. MIC 50 was 0.25 μg/ml and MIC90 was 1μg/ml. 
TABLE 15: MINIMUM INHIBITORY CONCENTRATIONS (MIC) 
FOR ITRACONAZOLE 
DRUG  ITRACONAZOLE MINIMUM INHIBITORY 
CONCENTRATION ( μg/ml ) 
FUNGI n 0.03 0.0625 0.125 0.25 0.5 1.0 2.0 4.0 8.0 16 
A. niger  51 2 7 8 11 13 10 - - - - 
A. flavus  14 1 5 3 1 2 2 - - - - 
A. terreus  4 - - - - 2 2 - - - - 
A. fumigatus  2 - - - - 1 1 - - - - 
Rhizopus 
oryzae 
2 - - - 1 - 1 - - - - 
Cladosporium 
cladosporoides 
2 - - - - 1 1 - - - - 
Aspergillus 
nidulans  
1 - - - - - 1 - - - - 
Aureobasidium 
pullulans 
1 - - - - 1 - - - - - 
Fonsaceae 
pedrosoi 
1 - - - - - 1 - - - - 
Rhizomucor 
pusillus 
1 - - - - - 1 - - - - 
Mucor 
circinelloides 
1 - - - - 1 - - - - - 
Curvularia 
lunata 
1 - - - - 1 - - - - - 
MIC of Itraconazole to Aspergillus niger in the range 0.03 – 1 μg/ml.  MIC 
50 was 0.25μg/ml and MIC90 was 1 μg/ml. For Aspergillus flavus the MIC range 
was 0.03 – 1 μg/ml. MIC 50 was 0.125 μg/ml and MIC90 was 1μg/ml. 
ANTIFUNGAL SUSCEPTIBILITY TESTING FOR CANDIDA 
SPECIES BY DISC DIFFUSION METHOD (CLSI M44) 
TABLE 16: SENSITIVITY PATTERN OF CANDIDA SPECIES TO 
ANTIFUNGALS 
Drug 
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albicans 
(n=20) 
20 
(100%) 
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19 
(95%) 
1 
(5%) 
20 
(100%) 
0 
18 
(90%) 
2 
(10%) 
20 
(100%) 
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Candida 
parapsilosis 
(n=2) 
2 
(100%) 
0 
2 
(100%) 
0 
2 
(100%) 
0 
1 
(50%) 
1 
(50%) 
2 
(100%) 
0 
Candida 
glabrata 
(n=1) 
- - 
1 
(100%) 
0 
1 
(100%) 
0 - - 
1 
(100%) 
0 
Candida 
krusei 
(n=1) 
- - 
1 
(100%) 
0 
1 
(100%) 
0 - - 
1 
(100%) 
0 
 
All isolates of Candida albicans were susceptible to Ampotericin B, 
Voriconazole and Itraconazole. 1 isolate was resistant to Itraconazole and 2 
isolates were resistant to Fluconazole. Among the 2 isolates of Candida 
parapsilosis, both were susceptible to Amphotericin B, Itraconazole, Voriconazole 
and Clotrimazole while 1 isolate was resistant to Fluconazole. The isolate of 
Candida glabrata was susceptible to Voriconazole, Itraconazole and 
Clotrimoxazole. The isolate of Candida krusei was susceptible to Voriconazole, 
Itraconazole and Clotrimazole. 
  
  


  
 
  
 

  
  
 
DISCUSSION 
Otomycosis is one of the most frequently encountered clinical condition in 
otorhinology. It is a superficial, acute, subacute or chronic fungal infection of the 
external auditory canal. The etiologic agents are saprophytic fungi, commonest 
being Aspergillus niger and Candida species. Although not life threatening, 
otomycosis can be a frustrating condition for both the patient and the treating 
doctor due to the requirement for a long term treatment, regular follow up and its 
tendency for recurrence.  
 
Of the 200 clinically suspected cases of otomycosis analysed, 105 samples 
showed fungal growth on culture accounting for 52.5%. This matches studies by 
Pankti Panchal et al
100
 which showed positive growth in 46% and Nowrozi et al
54
 
which showed a positive growth in 57%. It is in contrast to study by Agarwal et 
al
3
 where the positivity rate was 88.6%
 
. 
 
Fungus was isolated from all age groups ranging from 1 year to >60years. 
Among the positive cases, the youngest was a 5 year old male child, whose mother 
gave history of regular instillation of coconut oil in the ear. The eldest was a 72 
year old male patient who gave h/o uncontrolled Diabetes mellitus.  
 
Age distribution shows majority of the positive samples in the age group of 
21-30 years, with 27 cases ( 25.71%) followed by 31-40 years with 25 cases 
(23.81%). Least number of positive cultures were in the age group 1-10 years with 
2 cases. These findings are in concordance with studies by Channabasawaraj et 
al
65
, Yadav et al
102
 and Shilpa.K.Gokale et al
11
 which showed maximum number 
of cases in the age group 21-30 years with 28.3%, 35.36% and 33% respectively. 
Studies by Praveen Kumar Karn et al
103
 showed contrast to this study, where the 
maximum number of cases were in the age group 31-40 years followed by 21-30 
years. 
 
There was a female predominance observed in this study. Among the 
positive samples 62 were from females accounting for 59% and 43were from 
males with 41%. The female: male ratio was 1.44:1. These findings correlate with 
studies by Jyothi Swarup et al
50
 and J Fasunla et al
13
 which showed more number 
of cases among females than males.  Sampath Chandra Prasad et al
12
 and Kaur et 
al
105
 reported more cases among males than females.  
 
Otomycosis was observed to be unilateral in 101 cases (96%) and Bilateral 
in 4 cases (4%). Standard ENT reference books say that otomycosis is 
predominantly unilateral among immunocompetant individuals
4
. Likewise, 
Studies by Ho et al
83
 and Nandyal et al
112
 showed that majority of cases were 
unilateral (93%).  
 
Among those with Unilateral otomycosis, 19 Males (18.1%) and 34 
Females (32.4%) with a total of 53 cases (50.5%) showed a side predilection for 
the Right side. 23 Males (21.9%) and 25 Females (23.8%) with a total of 48 cases 
(45.7 %) showed predilection for the Left side. 
 
The same observation was seen in study by Paulose et al
80
 where most of 
the cases were unilateral with a slight predominance in the right side. As opposed 
to this, study by J Chander et al
82
 noted more cases in the left side while Yehia et 
al
106
 found no preference for either side. 
 
 Habitual cleaning of ears with unsterile materials like ear buds, safety pins, 
and match sticks was the common predisposing factor seen in 73 cases (70%). It 
matches ENT publications which relate use of unsterile materials with increased 
incidence of otomycosis due to microtraumas and inoculation of fungal 
spores
34,107,108
. 
   
Use of ear drops was observed in 41 cases(39%) as in studies by H S 
Sathish et al (48%)
118
. Oil instillation in ears was noted in 32 cases (31%) like in 
study by Rao et al (35.1%)
45
.  Previous history of CSOM was present in 22 cases 
(21%). Pus in CSOM along with the humid environment promotes growth of 
fungi
16,31
.Fungal culture positivity was identified in 26.15% cases of CSOM in 
study by Arun Ghosh et al
41
. Swimming/ cleaning ears with water during bathing 
was seen in 5 cases (5%) correlating with study by Surinder Singh et al
111
 (5%) as 
against other studies which showed higher percentage
109,110
.  H/o trauma or 
instrumentation of ears was present in 4 cases (4%) agreeing with findings by 
Deshmukh et al(4%)
17
. 
 
Diabetes mellitus as a co-morbid factor has been implicated in otomycosis. 
In our study, 17 patients had Diabetes mellitus as co-morbid illness (16%). This is 
in concordance with studies by Pankti Panchal et al
100
, Deshmukh et al
17
 and 
Senthil Kumaran et al
104
 where Diabetes mellitus as a co-morbid factor was 
observed in 10%,13% and 6% respectively. 
 
Aural pruritis was the most frequent symptom reported by 89 
patients(85%), which is in agreement with studies by Nandyal et al (93.37%)
112
 
and Sheik et al (90.38%)
113
. Fullness of the ear/ Ear block was the second 
common complaint seen in 73 cases (70%) as against observations by Mathur et 
al
36
 who found Ear block as a symptom in 93% of the patients. In this study, 
Otalgia was seen in 50 cases (48%), like in study by Viswanatha et al (40%)
10
. 41 
patients had Diminished hearing(39%) as a symptom while 37 had Ear Discharge 
(35%) as presenting complaint. This is in disagreement to study by Reena Ray et 
al
114
 where otorrhoea was the frequent complaint (58%). 6 patients presented with 
Tinnitus (6%), matching observations by Prasad et al
12
 and Dhingra  et al
47
 who 
noted Tinnitus in only 8% and 6% of cases respectively. 
 
On correlating KOH examination and culture positivity, it was observed 
that of the 105 culture positives, 101 were KOH positive. Sensitivity for diagnosis 
by culture was 100% and Sensitivity by KOH mount was 96%. Similar correlation 
between KOH examination and fungal culture was noted in studies by Kondity et 
al
115
, and Shilpa K Gokale et al
11
. Both KOH examination and fungal culture 
provide sensitive and reliable modalities of diagnosis. 
 
Literature search shows filamentous fungi as the commonest causative 
agent of otomycosis correlating with this study
1,2,19
. Out of the105 fungi isolated, 
81 were filamentous fungi (77%) and 24 were Candida species (23%). This is in 
accordance with studies by C Rodrigues et al
8
, Barati et al
116
 and Aneja et al
110
 
where the predominant isolates were filamentous fungi as opposed to studies by 
Zelia da Silva Pontes et al
117
 and Kumar H et al
69
 where Candida isolates were 
more than the filamentous isolates. 
 
Among the fungi isolated Aspergillus niger was the most common isolate 
in 51 cultures (49%), followed by Aspergillus flavus in 14 cultures (13%). 
Aspergillus terreus was isolated in 4 cultures. There were 2 isolates each of 
Aspergillus fumigatus and Rhizopus. The rare causative fungi isolated were 
Cladosporium(2), Aspergillus nidulans (1),Aureobasidium pullulans(1), 
Fonsaceae pedrosoi (1),  Curvularia lunata (1),  Mucor (1), and Rhizomucor (1).  
 
Of  the 24 Candida species isolated, 20 were Candida albicans, 2 were 
Candida parapsilosis, 1 was Candida glabrata and 1 isolate was Candida krusei. 
Studies by Vrutika V Gandhi et al
44
, Aneja et  al
110
, and Nagendran et al
84
 
identified Aspergillus niger as the common isolate followed by Aspergillus flavus. 
Candida was the 2
nd
 most common isolate in studies by Kondity et al
115
,  Sathish 
et al
118
 and Prakash et al
40
. The results are in contrast with findings of Mathur et 
al
36
 where Aspergillus fumigatus was isolated in 41.4% of the cases. Isolates of 
Aspergillus terreus, Cladosporium, Mucor, Rhizopus have been identified as 
etiological agents of otomycosis by A M Moharram et al
22
, Munguia et al
122
, 
Mugliston et al
15
. 
 
On performing Germ Tube test for identification of Candida, Germ tube 
test was positive for 20 out of the 24 Candida isolates. The 20 GTT positive 
isolates formed Germ Tube at 42°C.  Formation of Germ Tube at 42°C provides a 
100% sensitive test for identifying Candida albicans as shown in studies by 
Saranya et al
101
. 
 
Based on the colour of colonies on CHROMagar, 20 isolates of Candida 
albicans, 2 isolates of Candida parapsilosis, 1 isolate of Candida glabrata and 1 
isolate of Candida krusei were identified
94,95,97
 . 
 
Morphology and chlamydospore formation on Corn Meal agar by Dalmau 
technique was used to identify and speciate Candida isolates. 20 isolates of 
Candida albicans, 2 of Candida parapsilosis, 1 of Candida glabrata and 1 isolate 
of Candida krusei were identified
92,93
. 
 
On performing Sugar Assimilation test, all 20 isolates of Candida albicans 
assimilated glucose and maltose, 92% assimilated trehalose, 83% sucrose and 75% 
assimilated galactose. Both isolates of Candida parapsilosis assimilated glucose, 
galactose and trehalose while only 1 isolate assimilated sucrose and maltose. 
Candida glabrata assimilated glucose, maltose and trehalose. Candida krusei 
assimilated only glucose. This result correlates with the Standard Operating 
Procedures for identification of yeasts released by the Indian Council of Medical 
Research
92
. 
 
All 20 Candida albicans isolates fermented glucose and maltose while 18 
fermented trehalose(75%). Candida parapsilosis was able to ferment only 
glucose. Candida glabrata fermented glucose and trehalose and Candida krusei 
fermented only glucose matching the results of Standard Operating Procedures for 
identification of yeasts released by the Indian Council of Medical Research
92
. 
Virulence factors in fungi, determine the severity of the disease and its 
response to antifungal treatment. So testing for fungal virulence factors is an 
integral part of the laboratory diagnosis of fungi. 
 6 isolates of Candida albicans (29%) and 1 isolate of Candida parapsilosis 
were biofilm producers. This is similar to studies by Analy S Melo et al
121
 where 
biofilm formation was more among Candida albicans than Candida parapsilosis. 
 Urease production was seen in 78.57% of the Aspergillus flavus isolates 
and all 4 Aspergillus terreus isolates (100%). Urease production was not seen with 
Aspergillus niger, Aspergillus fumigatus and Aspergillus nidulans which matches 
findings by A.M.Moharram et al
22
. 
Hemolysin as a virulence factor was produced in 12 isolates of Aspergillus 
niger (23.53%), 4 isolates of Aspergillus flavus (28.57%), and 3 isolates of 
Aspergillus terreus (75%). In study by Raksha et al
23
 hemolysin was produced by 
83% of Aspergillus niger, 57% of A.flavus, 77% of Aspergillus fumigatus and 
100% of Aspergillus terreus.  
Aspergillus niger species showed higher production of Aflatoxins B1 and 
G1 while Aspergillus flavus and Aspergillus terreus produced more amounts of 
Aflatoxins B2 and G2. Aflatoxins induce teratogenicity and mutagenicity usually 
on ingestion or inhalation. Studies by Boonen et al
29
 and Rastogi et al
30
 have 
documented permeation of aflatoxin through the skin. In depth studies are needed 
to identify the mutagenic and teratogenic potential of fungi involved in 
otomycosis. 
Molecular Diagnosis:  
2 of the rare isolates were subjected to PCR followed by Sanger sequencing 
for speciation. 270 bp pan fungal genome was identified and sequenced by 
Sanger‟s dideoxynucleotide sequencing method. Individual nucleotide-nucleotide 
searches were done with the BLASTn algorithm at the NCBI website. Sequence-
based identities with a cut-off of 97% was obtained for both isolates and the fungi 
were identified as Cladosporidium cladosporoides. 
All the diagnosed cases were treated with Clotrimazole 1% ear drops or 
plugging of ear with Miconazole ointment applied in gauze. The patients were 
followed up at 1, 2, 4 and 12 weeks. All the patients showed good response to 
treatment with negative culture by 2 weeks of treatment. Antifungal susceptibility 
testing to commonly used antifungal drugs was done by Microbroth dilution 
method to determine the Minimum Inhibitory Concentration (MIC) of the 
antifungal agents to the fungal isolates. 
MIC of Clotrimazole to Aspergillus niger was in the range 0.03 – 1μg/ml. 
MIC50 was 0.25μg/ml and MIC90 was 1 μg/ml. For Aspergillus flavus the MIC 
range was 0.03 – 1 μg/ml. MIC 50 was 0.125 μg/ml and MIC90 was 0.5 μg/ml. 
MIC of Amphotericin B to Aspergillus niger was in the range 0.03 – 
1μg/ml. The MIC 50 was 0.5μg/ml and MIC90 was 1 μg/ml. For Aspergillus 
flavus the MIC range was 0.0625 – 1 μg/ml. The MIC 50 was 0.5 μg/ml and 
MIC90 was 1 μg/ml. 
MIC of Voriconazole to Aspergillus niger was in the range 0.03 –1 μg/ml. 
MIC 50 was 0.25μg/ml and MIC90 was 0.5 μg/ml. For Aspergillus flavus the MIC 
range was 0.03 – 1 μg/ml. MIC 50 was 0.25 μg/ml and MIC90 was 1μg/ml. 
MIC of Itraconazole to Aspergillus niger in the range 0.03 – 1 μg/ml. The 
MIC 50 was 0.25μg/ml and MIC90 was 1 μg/ml. For Aspergillus flavus the MIC 
range was 0.03 – 1 μg/ml. MIC 50 was 0.125 μg/ml and MIC90 was 1 μg/ml. 
Among the 20 isolates of Candida albicans tested, all isolates were 
susceptible to Ampotericin B, Voriconazole and Itraconazole. 1 isolate was 
resistant to Itraconazole and 2 isolates were resistant to Fluconazole. Among the 2 
isolates of Candida parapsilosis, both were susceptible to Amphotericin B, 
Itraconazole, Voriconazole and Clotrimazole while 1 isolate was resistant to 
Fluconazole. The isolate of Candida glabrata was susceptible to Voriconazole, 
Itraconazole and Clotrimoxazole. The isolate of Candida krusei was susceptible to 
Voriconazole, Itraconazole and Clotrimazole. 
 
 
 
 
 
 
 
 
 
 
 
SUMMARY 
 Otomycosis is one of the common infections of the ear prevalent in the 
tropical and subtropical regions.  
 In this study, fungi was isolated from 105 cases (52.5%) of clinically 
suspected otomycosis. High prevalence could be due to the hot and humid 
climatic conditions prevalent in this region. 
 Otomycosis was seen in all age groups with the highest number of cases in 
the age group 21-30 years (25.71%) followed by 31-40 years (23.81%). 
This could be due to maximum exposure in these age groups to 
environmental spores. 
 There was a female predominance with 62 cases in females (59%) and 43 
cases in males (41%). Majority of the cases were unilateral (96%) while 
only 4 were bilateral (4%).  
 Among predisposing factors, habitual cleaning of ear with unsterile 
materials (70%) was found to be the commonest followed by injudicious 
use of antibiotic/ steroid ear drops (39%). 
  Uncontrolled diabetes was the most frequent comorbid condition 
associated with otomycosis (16%). 
 On correlation of diagnosis by microscopy and culture, culture showed a 
sensitivity of 100%, specificity of 95.96%, positive predictive value of 
96.19%, negative predictive value of 100% with a diagnostic accuracy of 
98% validating culture as a reliable test for diagnosis. 
 Among fungi causing otomycosis, filamentous fungi were isolated from 81 
samples (77%). Aspergillus niger was the commonest etiological agent in 
otomycosis(49%) followed by Candida albicans (19.1%), Aspergillus 
flavus (13%), Aspergillus terreus(4%), Aspergillus fumigatus(2%), 
Rhizopus(2%).  
 Rare isolates were Cladosporium cladosporoides (2), Aspergillus nidulans 
(1), Aureobasidium pullulans(1), Fonsaceae pedrosoi (1),  Curvularia 
lunata (1),  Mucor (1),  Rhizomucor (1), Candida parapsilosis (2), Candida 
glabrata (1) and Candida krusei(1).  
 Candida species can be reliably speciated based on germ tube test, colour 
of colonies on CHROMagar, morphology on Dalmau plating, sugar 
assimilation and sugar fermentation tests as shown in this study. 
 Identification of virulence factors is an important part of diagnosis in 
fungal infections as it determines the severity of infections as well as its 
response to treatment. In this study, biofilm production was seen with 6 
isolates of Candida albicans (29%) and 1 isolate of Candida parapsilosis. 
 Hemolysin as a virulence factor was produced in 12 isolates of Aspergillus 
niger (23.53%), 4 isolates of Aspergillus flavus(28.57%), and 3 isolates of 
Aspergillus terreus (75%).  
 Aspergillus niger species showed higher production of Aflatoxins B1 and 
G1 while Aspergillus flavus and Aspergillus terreus produced more 
amounts of Aflatoxins B2 and G2. Aflatoxin B1 has been shown to 
permeate the skin.  In depth studies are needed to identify the mutagenic 
and carcinogenic potential of Aspergillus species involved in otomycosis 
 2 of the rare isolates were subjected to PCR followed by Sanger sequencing 
for speciation and identified as Cladosporidium cladosporoides. Sequence-
based identities serves as a reliable method for identification of rare fungi 
as well for estimating drug resistance. 
 The diagnosed cases were treated with Clotrimazole 1% ear drops or 
plugging of ear with Miconazole ointment applied in gauze. The patients 
were followed up at 1, 2, 4 and 12 weeks. All the patients showed good 
response to treatment with negative culture by 2 weeks of treatment. There 
was no recurrence on follow up for 3 months. 
 All the filamentous fungi were susceptible to commonly used antifungals 
like Clotrimoxazole, Amphotericin B, Voriconazole and Itraconazole tested 
by microbroth dilution method, with MIC ranging between 0.03 –1μg/ml.  
 Among the 20 isolates of Candida albicans tested, 1 isolate was resistant to 
Itraconazole and 2 isolates were resistant to Fluconazole. Among the 2 
isolates of Candida parapsilosis, 1 isolate was resistant to Fluconazole. The 
isolate of Candida glabrata was susceptible to Voriconazole, Itraconazole 
and Clotrimoxazole. The isolate of Candida krusei was susceptible to 
Voriconazole, Itraconazole and Clotrimazole. 
Otomycosis is challenging for both patients and otolaryngologist as it 
frequently requires long term treatment and follow up . In recent years there has 
been an increased awareness about fungal infections and a high degree of clinical 
suspicion among doctors in diagnosing otomycosis. Removal of predisposing 
factors is the first step in treating otomycosis which can be achieved by proper 
counselling of the patients. 
More in-depth studies on the various otomycosis causing fungi and their 
degree of sensitivity to currently available antifungal drugs will help the clinician 
in diagnosing and refining treatment of otomycosis.  
  
CONCLUSION 
 Otomycosis is  a frequently encountered infection of the ear in our region.  
 Habitual cleaning of ears with unsterile materials is the major predisposing 
factor and should be avoided. 
 Injudicious use of antibiotic or steroid ear drops can lead to worsening as 
well as persistence of otomycosis.  
 Aspergillus and Candida are the most common etiological agents of 
otomycosis. 
  Fungi like Cladosporium, Aureobasidium, Fonsaceae, Mucor, Rhizopus, 
Rhizomucor and Curvularia are also isolated in otomycosis. 
 Analysis of virulence factors showed biofilm formation in Candida.  
 Production of Urease and Hemolysin were identified as virulence factors 
among Aspergillus species.  
 On testing production of Aflatoxins among the Aspergillus species , 
Aspergillus niger species showed higher production of Aflatoxins B1 and 
G1 while Aspergillus flavus and Aspergillus terreus produced more 
amounts of Aflatoxins B2 and G2.  
 PCR and Gene sequencing are reliable methods for identification and 
speciation of rare fungi. 
 All the patients showed good response to treatment with topical 
clotrimoxazole drops or miconazole ointment . 
 Otomycosis is a benign condition which responds well to topical 
antifungals.  
 Diagnosis of otomycosis at the earliest, confirmation with various tests for 
virulence and identification of antifungal susceptibility pattern is 
mandatory to effectively manage otomycosis without complications or 
recurrence. 
 
 
 
  
  
 
 
  
PROFORMA 
NAME   : 
AGE/SEX  : 
ADDRESS  : 
OCCUPATION : 
OP /IP No  :  
LAB No  :  
SYMPTOMS  : 
1. AURAL PRURITIS  - 
2. OTALGIA   - 
3. EAR DISCHARGE  - 
4. EAR BLOCK - 
5. HARD OF HEARING - 
6. TINNITUS   - 
PREDISPOSING FACTORS/ COMORBID CONDITIONS: 
a. EXCESSIVE EXPOSURE TO WATER 
b. USE OF EAR DROPS 
c. USE OF OIL 
d. TRAUMA 
e. HABITUAL CLEANING OF EAR CANAL WITH BUDS, FINGER TIPS, 
SAFETY PINS, ETC. 
f. DIABETES 
g. CSOM 
h. POST RADIOTHERAPY 
i. IMMUNOCOMPROMISED 
CLINICAL DIAGNOSIS : 
SAMPLE COLLECTED: 
LAB DIAGNOSIS : 
 EXAMINATION UNDER MICROSCOPE: 
1. GRAM’s STAIN 
2. KOH MOUNT 
 CULTURE CHARACTERSTICS : On Emmons modified Sabouraud dextrose agar, 
  LPCB STAIN: 
 SPECIES IDENTIFICATION AND CHARACTERISATION : 
 ANTIFUNGAL SUSCEPTIBILITY TESTING : 
SPECIES IDENTIFIED: 
 
Signature of Investigator     Signature of the Guide 
PATIENT CONSENT FORM 
 
ISOLATION, CHARACTERISATION AND ANTIFUNGAL SENSITIVITY 
PATTERN OF FUNGI CAUSING OTOMYCOSIS IN PATIENTS REPORTING 
IN A TERTIARY CARE HOSPITAL 
 
STUDY CENTER :  KILPAUK MEDICAL COLLEGE AND HOSPITAL, CHENNAI. 
PATIENT NAME :       PATIENT AGE: 
IDENTIFICATION NUMBER: 
PATIENT TO TICK (        )THESE BOXES  
 
I confirm that I have understood the purpose of procedure for the above study.  
I have the opportunity to ask the question and all my questions and doubts have been 
answered to my satisfaction.                                                                          (          ) 
 
I understand that my participation in the study is voluntary and that I am free to withdraw 
at anytime without giving any reasons, without my legal rights being affected.      
(          ) 
 
I understand that the investigator, regulatory authorities and the ethics committee will not 
need my permission to look at my health records both in respect to the current study and 
any further research that may be conducted in relation to it, even if withdraw from the 
study, I understand that my identity will not be revealed in any information released to 
third parties or published, unless as required under the law. I agree not to restrict the use 
of any data or results that arise from the study.                                                                          
(          ) 
 
I agree to take part in the above study and to comply with the instructions given during 
the study and faithfully cooperative with the study team and to immediately inform the 
study staff if I suffer from any deterioration in my health or wellbeing or any unexpected 
or unusual symptoms.                                                                                                             
(           ) 
 
I hereby give consent to participate in this study. 
I hereby give permission to undergo complete clinical examination and diagnostic test. 
 
Signature/Thumb impression:     Place:   Date: 
 
Patient name and address: 
 
 
Signature of the investigator:     Place:                          Date: 
Study investigator‟s name:  
சுய ஒப்புதல் படிவம் 
 
ஆய்வு செய்னப்஧டும் தல஬ப்பு: ISOLATION, CHARACTERISATION AND 
ANTIFUNGAL SENSITIVITY PATTERN OF FUNGI CAUSING 
OTOMYCOSIS IN PATIENTS REPORTING IN A TERTIARY CARE 
HOSPITAL 
ஆய்வு செய்னப்஧டும் இடம்: கீழ்஧ாக்கம் அபசு நருத்துவக்கல்லூரி நற்றும்                                            
நருத்துவநல஦, சென்ல஦-10 
஧ங்கு ச஧று஧வரின் ச஧னர்: 
஧ங்கு ச஧று஧வரின் வனது:                    ஧ங்குச஧று஧வரின் எண் : 
 
மநம஬ கு஫ிப்஧ிட்டுள்஭ நருத்துவ ஆய்வின் விவபங்கள் எ஦க்கு 
வி஭க்க஧ட்டுள்஭து. ஥ான் இவ்வாய்வில் தன்஦ிச்லெனாக ஧ங்மகற்கின்ம஫ன். எந்த 
காபணத்தி஦ாம஬ா, எந்த ெட்ட ெிக்கலுக்கும் உட்஧டாநல் ஥ான் இவ்வாய்வில் 
இருந்து வி஬கிக் சகாள்஭஬ாம் என்றும் அ஫ிந்துசகாண்மடன். 
இந்த ஆய்வு ெம்஧ந்தநாகமவா, இலத ொர்ந்து மநலும் ஆய்வு 
மநற்சகாள்ல௃ம் ம஧ாதும் இந்த ஆய்வில் ஧ங்குச஧றும் நருத்துவர் என்னுலடன 
நருத்துவர் என்னுலடன நருத்துவ அ஫ிக்லககல஭ ஧ார்ப்஧தற்கு என் அனுநதி 
மதலவ இல்ல஬ எ஦ அ஫ிந்து சகாள்கிம஫ன். இந்த ஆய்வின் மூ஬ம் கிலடக்கும் 
தகவல஬மனா,முடிலவமனா ஧னன்஧டுத்திக் சகாள்஭ நறுக்கநாட்மடன். 
இந்த ஆய்வில் ஧ங்கு சகாள்஭ ஒப்புக் சகாள்கிம஫ன். இந்த ஆய்லவ 
மநற்சகாள்ல௃ம் நருத்துவ அணிக்கு உண்லநம௃டன் இருப்ம஧ன் என்று 
உறுதின஭ிக்கிம஫ன். 
஧ங்மகற்஧வரின் லகசனாப்஧ம்:                 ொட்ெினா஭ரின் 
லகசனாப்஧ம் 
இடம் :                                                                                             இடம் : 
மததி :                                                                                             மததி  : 
஧ங்மகற்஧வரின் ச஧னர் நற்றும் வி஬ாெம்: 
 
ஆய்வா஭ரின்  லகசனாப்஧ம்: 
இடம் :                                         
மததி :           
 
APPENDIX 
 
POTASSIUM HYDROXIDE MOUNTS (10% KOH): 
The aqueous Potassium hydroxide (KOH) acts as a clearing agent, 
dissolving the cellular debris without affecting the fibrillar glucan and chitin 
structure of the fungal cell wall.  
Composition: 
Potassium hydroxide         10gm 
Glycerol                             20ml 
Distilled Water                   80ml 
 
 To solution of 10% KOH, 10% glycerol is added to prevent drying. 
  Mix these ingredients properly.  
 Store solution at room temperature.  
LACTOPHENOL COTTON BLUE STAIN 
The Lactophenol Cotton Blue (LPCB) mount is used to study morphological 
features of fungal isolates.  
Composition: 
Melted Phenol  : 20ml 
Lactic Acid    : 20ml 
Glycerol    : 40ml 
Cotton Blue    : 0.05gm 
Distilled Water : 20ml 
 Dissolve 0.05gm of Cotton Blue stain in distilled water before mixing 
with remaining reagents.  
 Mix all the reagents thoroughly.  
 Store at room temperature. 
 The phenol acts as disinfectant, lactic acid preserves morphology of fungi 
and glycerol is hygroscopic agent which prevents drying. The Cotton Blue 
stains outer wall of fungus. 
SABOURAUD’S DEXTROSE AGAR (SDA): 
Composition: 
Dextrose  : 40g 
Peptone  : 10g 
Agar   : 20g 
Distilled water : 1 litre 
 Mix reagents by boiling  
 Dispense in tubes 
 Autoclave at 121 ºC for 15 minutes 
 Adjust pH of 5.5 to 5.6 
 Add Gentamicin 50 μg/ml or Chloramphenicol 50 μg/ml and mix well 
 Allow tubes to cool at slanted position 
 Store at 4 ºC 
 Shelf life: 30 days for tubes and 14 days for petridishes. 
  
EMMON’S MODIFICATION OF SABOURAUD’S DEXTROSE AGAR: 
Composition: 
Dextrose   : 20g 
Peptone  : 10g 
Agar   : 20g 
Distilled water : 1 litre 
 Mix reagents by boiling 
 Dispense in tubes 
 Autoclave at 121 ºC for 15 minutes 
 Adjust pH to 6.9±0.2 
 Add Gentamicin 50 μg/ml or Chloramphenicol 50 μg/ml and mix well 
 Allow tubes to cool in slanted position  
 Store at 4 ºC 
 Shelf life: 30 days for tubes and 14 days for petridishes. 
POTATO DEXTROSE AGAR (PDA): 
Composition: 
Potatoes   : 250g 
Dextrose  : 20g 
Agar   : 20g 
Distilled water : 1000ml 
 Peel, slice and boil potatoes in 100ml distilled water for 1 hour 
 Filter with gauze 
 Add dextrose and agar. 
 Add distilled water to make final volume upto 1000ml. 
 Bring to boil to dissolve agar. 
 Autoclave at 121 ºC for 15 minutes. 
 
CORN MEAL AGAR: 
Composition: 
Corn meal  : 40g 
Distilled water : 1litre 
Agar   : 20g 
 Heat Corn meal in a water bath at 60ºC for one hour. Filter through gauze. 
 Make up filtrate to 1000 ml with distilled water. 
 Add 2% agar 
 Autoclave at 121 ºC for 15 minutes. 
 Dispense in sterile petridishes. 
 Shelf life: 14 days 
CHROMAGAR- CANDIDA DIFFERENTIAL AGAR: 
Available as a readymade powder with Himedia. Used for rapid isolation, 
identification and speciation of Candida species. 
Composition: 
Peptone     : 15 g/litre 
Yeast extract    : 4 g/litre 
Dipotassium hydrogen phosphate : 1 g/litre 
Chromogenic mixture   : 7.22 g/litre 
Chloramphenicol   : 0.5g /litre 
Agar     : 15 g/litre 
Distilled water   : 1000 ml 
 Suspend 42.72 gms in 1000ml of distilled water. 
 Heat to boiling to dissolve the medium completely. 
 Do not autoclave. 
 Cool to 45 – 50 ºC 
 Adjust pH to 6.3±0.2 
 Mix well and pour into sterile petridishes. 
YEAST NITROGEN BASE: 
Composition: 
PART A: 
Noble agar   : 25.0g 
Distilled water   : 1 litre 
PART B: 
Yeast Nitrogen Base   :  6.7g/100 ml distilled water 
 Suspend40 gms in 900 ml distilled water.  
 Heat to boiling to dissolve the medium completely. 
 Autoclave at 121 ºC for 15 minutes. 
 Cool to 50 ºC and aseptically mix sterile Part B solution inoculated with the 
yeast colonies. 
 Add 3 ml of sterile 5% Tartaric acid for 100 ml of the mixture just before 
pouring the plate. 
  
MCFARLAND TURBIDITY STANDARD FOR INOCULUM PREPARATION 
A Barium sulphate 0.5 McFarland standard was prepared as follows 
 
1. A 0.5 ml of 0.048mol/L of Barium chloride was added to 99.5 ml of 0.18 
mol/L of H2SO4 with constant stirring to maintain a suspension.  
 
2. Correct density of the turbidity standard was verified by using a 
spectrophotometer. The absorbance of 625nm should be 0.08 to 0.10 for the 
0.5 McFarland standards. 
 
3. The Barium sulphate suspension was transferred in 4-6 ml to a screw capped 
tube of the same size as those used in growing or diluting the bacterial 
inoculum. 
 
4. These tubes were tightly sealed and stored in the dark at room temperature. 
 
5. The Barium sulphate turbidity standard was vigorously agitated before each 
use and inspected for a uniform turbid appearance 
  
Candida Speciation On ChromAgar And Corn Meal Agar: 
SPECIES CHROMAGAR CORN MEAL AGAR 
Candida albicans Apple green colonies Abundant pseudohyphae. 
Budding cells, spherical 
chlamydospores mostly terminal 
often on a swollen subtending 
cell. 
Candida tropicalis Metallic blue to purple 
infused into surrounding 
agar with pale pink edges 
Abundant pseudohyphae with 
blastoconidia. Budding cells 
ellipsoidal. Long poorly 
branched elements often 
narrowed towards a sterile apex. 
Conidia arranged in small groups 
around middle of each cellular 
element. 
Candida parapsilosis White to pale pink Clusters of blastospores with 
occasional giant cells. 
Candida krusei Large, flat, spreading, pale 
pink colonies with matt 
surface 
Branched pseudomycellium. 
Budding cells ellipsoidal to 
cylindrical. Cells liberated and 
arranged parallel to the main 
axis. 
Candida glabrata White, large, glossy, pale 
pink to violet 
Pseudohyphae not present. 
Budding unipolar cells 
ellipsoidal, typically arranged in 
dense groups. Chlamydospore 
absent. 
Candida 
guillermondii 
Small, pink to purple 
colonies 
Pseudohyphae with clusters of 
blastospores radiating from the 
centre of masses of spherical to 
broadly ellipsoidal budding cells. 
Candida lusitaniae Pink, gray purple colonies Branched pseudohyphae present. 
Candida famata White to light pink colonies Pseudohyphae absent. 
Candida haemuloni  Pseudohyphae absent. Spherical 
budding cells. 
Candida auris  Pseudohyphae absent. Ovoid to 
ellipsoidal budding cells. 
 
SPECIATION OF CANDIDA BY SUGAR ASSIMILATION TEST 
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Galactose + + + - + - + V 
Sucrose V V + - + - + + 
Maltose + + + - + - + + 
Cellobiose - + - - + - - - 
Trehalose + + + - + - + + 
Lactose - - - V + - - - 
Melibiose - - V - - - - - 
SPECIATION OF CANDIDA BY SUGAR FERMENTATION TEST: 
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Glucose + + + + + + + + 
Galactose V + V - V - V - 
Sucrose - V - - + - - + 
Maltose + + + - - - - - 
Raffinose - - - - + - - - 
Trehalose V + V V + - - + 
ANTIFUNGAL SUSCEPTIBILITY TEST BY MICROBROTH 
DILUTION METHOD 
Scheme for Preparing Dilution of Water Insoluble Antifungal Agents: 
 
 
 
 
 
Antimicrobial Solution 
Step 
Concentration 
(µg/ml) 
Source 
Volume 
(ml) 
Solvent 
(ml) 
Intermediate 
Concentration 
(µg/ml) 
Final 
Concentration 
At 1:50 (µg/ml) 
1 1600 Stock 0.5  1600 32 
2 1600 Stock 0.5 0.5 800 16 
3 1600 Stock 0.5 1.5 400 8 
4 1600 Stock 0.5 3.5 200 4 
5 200 Step 4 0.5 0.5 100 2 
6 200 Step 4 0.5 1.5 50 1 
7 200 Step 4 0.5 3.5 25 0.5 
8 25 Step 7 0.5 0.5 12.5 0.25 
9 25 Step 7 0.5 1.5 6.25 0.125 
10 25 Step 7 0.5 3.5 3.13 0.0625 
Scheme for Preparing Dilution of Water Soluble Antifungal Agents: 
Antimicrobial Solution 
Step 
Concentration 
(µg/ml) 
Source 
Volume 
(ml) 
Solvent 
(ml) 
Intermediate 
Concentration 
(µg/ml) 
Final 
Concentration 
At 1:50 (µg/ml) 
1 5120 Stock 1 7 640 128 
2 640 Step1 1 1 320 64 
3 640 Step1 1 3 160 32 
4 160 Step3 1 1 80 16 
5 160 Step3 0.5 1.5 40 8 
6 160 Step3 0.5 3.5 20 4 
7 20 Step6 1 1 10 2 
8 20 Step6 0.5 1.5 5 1 
9 20 Step6 0.5 3.5 2.5 0.5 
10 2.5 Step9 1 1 1.25 0.25 
 
 
 
 
 
ABBREVIATION 
 
BLAST   -  Basic Local Alignment Search Tool 
CLSI    - Clinical Laboratory Standards Institute 
CSOM    - Chronic Suppurative Otitis Media 
DNA     - Deoxyribonucleic acid 
ELISA   - Enzyme Linked Immunosorbent Assay 
E- TEST   - Epsilometer Test 
EUCAST   - European Committee on Antibiotic  
Susceptibility Testing  
GTT     - Germ Tube Test 
HPLC    -  High Performance Liquid Chromatography 
IMC     - Isothermal Micro Calorimetry  
ITS     -  Internal Transcribed Spacer  
KOH    - Potassium hydroxide 
LPCB    -  Lactophenol Cotton Blue 
MALDI –TOF  -  Matrix Assisted Laser Desorption/Ionisation –                                              
     Time of Flight. 
MEC    -  Minimal Effective Concentration 
MIC    -  Minimum Inhibition Concentration 
NCBI    -  National Center for Biotechnology Information 
OD    -  Optical density 
OPD    -  Out Patient Department 
PBS     -  Phosphate Buffered Saline  
PCR    -  Polymerase Chain Reaction 
PDA     -  Potato Dextrose Agar   
rDNA     -  ribosomal DNA  
RPMI-1640   -  Roswell Park Memorial Institute-1640 medium 
SDA     -  Sabouraud Dextrose Agar 
SSPS    -  Statistical Package for the Social Sciences  
 
 
 
 
 
 
 
 
 
 
 
 
KEY TO MASTER CHART 
 
M    -  Male 
F    -  Female 
1    -  Aural Pruritis 
2    - Otalgia 
3   -  Ear Discharge 
4    -  Ear Block/ Feeling of Fullness  
5    -  Diminished Hearing 
6    -  Tinnitus 
a   - Swimming 
b    -  Use of Antibiotics/ Steroid Ear Drops 
c    -  Oil Instillation in Ears 
d    -  Trauma/ Previous Ear Surgery 
e    -  Habitual Cleaning of Ear with Unsterile  
                                          materials  
f    -  Diabetes melitus 
g   -  H/o CSOM 
POS    -  Positive 
NEG   -  Negative 
CHROM  -  Colour on CHROM agar 
A    -  Apple green colonies  
B    -  White,pale pink to violet  
C    -  White to pale pink  
D    -  Large, flat, spreading, pale pink colonies  
with matt surface 
 
CMA   -  Morphology on Corn Meal Agar  
 
7   -  Abundant pseudohyphae. Budding cells,  
terminal spherical chlamydospores  
 
8    -  Pseudohyphae absent. Budding unipolar.  
Cells ellipsoidal 
 
9    -  Clusters of blastospores  
 
10    -  Branched pseudomycellium. Budding cells  
ellipsoidal and parallel to the main axis 
 
P    -  Produced 
A.niger   -  Aspergillus niger 
A.flavus   -  Aspergillus flavus 
A.fumigatus  -  Aspergillus fumigatus 
A.terreus  -  Aspergillus terreus 
A.nidulans   -  Aspergillus nidulans 
C.albicans   -  Candida albicans 
C.parapsilosis  -  Candida parapsilosis 
C.glabrata   -  Candida glabrata 
C.krusei   -  Candida krusei 
NG    -  No Growth 
NP    -  Not Produced 
H    -  Hydrolysed 
NH    -  Not Hydrolysed 
NA    -  Not Applicable 
HE    -  Hemolytic 
NHE    -  Non Hemolytic 
CLO    -  Clotrimoxazole 
ITR    -  Itraconazole 
VOR    -  Voriconazole 
FLU    -  Fluconazole 
AMP    -  Amphotericin B 
S    -  Susceptible 
R    -  Resistant 
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1 291 25 F 2 b,c,e   1,3 left  POS A 7 C. albicans NP       S S S S S 
2 18 26 M 3 b   1,2 left        NG                   
3 669 19 F 6 b,e   2,3,4 right       A.niger   NH NHE   S  S  S S  S  
4 985 41 M 7 b,e f 1,3 left  NEG B 8 C. glabrata NP       S S NA NA S 
5 607 45 M 9 c,e   1,2,3 right       A.niger   NH HE B1,G1,B2,G2 S  S  S S  S  
6 1725 48 F 10 e f 1,2,4,6 bilateral POS A 7 C. albicans P        S R R S S 
7 1855 22 F 12 b,c   1,2,3 right POS A 7 C. albicans NP       S S S S S 
8 1514 23 M 13 a,c,e   1,3,4 left        A.niger   NH NHE   S  S  S S  S  
9 2927 73 F 14 c   1,2,4,5 right       A.niger   NH HE   S  S  S S  S  
10 2003 21 M 15 a    1,4,5 right       NG                   
11 2052 70 M 20 b,e f 1,5 left        A.niger   NH HE   S  S  S S  S  
12 2256 24 M 21 e   1,4 right       NG                   
13 2160 17 M 34 e   1,2,4 right       Fonsaceae   NA NA   S  S  S S  S  
14 2322 29 M 39 c   1,2,5 left        A.niger   NH NHE   S  S  S S  S  
15 476 41 F 40 i,j   1,2 left        NG                   
16 2361 31 F 49   f 1,4,5 right       A.flavus   H HE B1,G1,B2,G2 S  S  S S  S  
17 4252 72 M 60 b f 1,3,4,5 right NEG C 9 C. 
parapsilosis 
NP       S S S S S 
18 4267 32 M 65 b   1,2,4,5 left        A.niger   NH NHE   S  S  S S  S  
19 5089 20 M 66 a,g   1,2,5 right POS A 7 C. albicans NP       S S S S S 
20 5162 30 M 67 b   1,5 right       A.niger   NH NHE   S  S  S S  S  
21 6671 16 M 90 a,g   3,4 left        A.flavus   NH NHE   S  S  S S  S  
22 837 50 F 91 b,c,e   1,2,3,4 right       NG                   
23 8303 16 M 92 b,d   2,3,4 left        NG                   
24 5365 15 M 93 a,e   2,3,4 left        NG                   
25 4947 42 F 94 e   1,3,4 right       A.flavus   H NHE   S  S  S S  S  
26  978 50 M 95 e f 1,2,4,5 left        A.fumigatus   NH HE   S  S  S S  S  
27 8663 18 F 96 e   1,2,4 left        A.niger   NH NHE   S  S  S S  S  
28 9589 60 M 97   f 1,5 bilateral       A.niger   NH HE B1,G1,B2,G2 S  S  S S  S  
29 3168 46 M 99 e   1,3 right       NG                   
30 4354 57 F 100 c,e   1,2,3 right       NG                   
31 8345 51 M 101 b,c f 2,3,4 left        NG                   
32 8981 32 F 102 e   2,3 left        NG                   
33 10252 28 F 103 e   2,3,4 right       NG                   
34 10526 38 F 104 c,e   1,4 right       A.niger   NH NHE   S  S  S S  S  
35 10312 30 M 105 e,g   1,2,3 right POS A 7 C. albicans P        S S S S S 
36 10152 20 M 106 b   1,2 left        NG                   
37 11032 9 M 107 b,c   1,4 right       A.niger   NH NHE   S  S  S S  S  
38 8576 29 F 108 e   1,2,3,4 left  POS A 7 C. albicans NP       S S S S S 
39 10032 35 F 109 b,c,e    1,4 left        Rhizomucor   NA NA   S  S  S S  S  
40 8242 38 F 110 e   1,4 left       A.niger   NH HE   S  S  S S  S  
41 11279 52 F 111 b   1,2,3,4 right       A.flavus   H HE   S  S  S S  S  
42 14246 25 M 112 c,e   1,4,5 right       Aureobasidiu
m 
  NA NA   S  S  S S  S  
43 13169 65 F 113 c,e   2,3 bilateral       NG                   
44 13377 70 F 114 e   1,4,5 right       Cladosporium   NA NA   S  S  S S  S  
45 13673 25 F 115 c,e   1,2,4 left        A.terreus   H HE   S  S  S NA S  
46 1444 39 M 116 b,c   1,3,4 left        A.niger   NH NHE   S  S  S S  S  
47 20316 48 M 117 c,e,j   1,2,3,5 right       NG                   
48 11865 64 M 118 e f 1,2 left        NG                   
49 19096 54 M 119 e f 1,2,3 bilateral       NG                   
50 20230 46 M 120 b,c f 1,4 right       NG                   
51 23046 77 F 121 c,e f 2,4,5 left        NG                   
52 23321 32 M 122 e f 1,2,3,5 right       A.terreus   H HE   S  S  S NA S  
53 27021 40 M 123 a    1,3,5 left        NG                   
54 13793 39 F 124 c,e   2,5 right       NG                   
55   9218 90 M 125 b,e f 1,2,4,5 right       NG                   
56 32609 45 M 126 e   1,5 right       NG                   
57 20316 35 F 127 c,e   1,4 left        A.niger   NH NHE   S  S  S S  S  
58 17010 64 M 128 b,e,g f 1,2,4 right       A.niger   NH HE   S  S  S S  S  
59 25246 36 F 129 e   1,2,4,5 right       A.niger   NH NHE   S  S  S S  S  
60 21632 60 M 130 e   2,3 bilateral       NG                   
61 34647 25 M 132 e   4,5 left        NG                   
62 11652 14 F 133 c   1,2,3 left        NG                   
63 35676 25 F 134 c    1,2,3 right       NG                   
64 1425 47 M 136 b,c   2,3 right       NG                   
65 22555 16 F 137 e   2,3,5 right       NG                   
66 38911 22 F 138 e,g   1,2,3,4 right       A.terreus   H NHE   S  S  S NA S  
67 1435 46 F 139 e   2,4,5 left        A.flavus   H HE B1,G1,B2,G2 S  S  S S  S  
68 41632 66 M 140 e,g   1,3 right NEG C 9 C. 
parapsilosis 
P        S S R S S 
69 1412 30 F 142 b,e   1,2,4 right       A.niger   NH NHE   S  S  S S  S  
70 41905 39 F 143 b,c   1,2,3,4 left        NG                   
71 42968 36 F 144 b,e   1,4,5 left        NG                   
72 17127 58 M 145 e f 1,4,6 right       A.niger   NH HE   S  S  S S  S  
73 30798 38 F 146 a,c,e   3,4 left        NG                   
74 42857 42 F 147 c,g   1,2,4,5 left        A.nidulans   NH NHE   S  S  S S  S  
75 1487 75 F 148 g f 1,2,3,G12
24 
right       NG                   
76 41058 17 M 155 b   1,2,5 right       NG                   
77 43428 47 M 156 b,e f 2 left        NG                   
78 2133 34 M 158 b   1,2,5 right       A.flavus   H HE   S  S  S S  S  
79 51815 25 M 159 b,c,e   3 left        NG                   
80 52590 35 F 160 e   2,4,5 right       A.niger   NH NHE   S  S  S S  S  
81 42027 28 F 166 c,e   1,4,5 left        A.niger   NH NHE   S  S  S S  S  
82 1841 41 F 170 b,c,e   1,4 left        A.niger   NH NHE   S  S  S S  S  
83 40808 20 F 171 b,e,g   1,6 right       A.niger   NH NHE   S  S  S S  S  
84 27391 46 M 172 d    1,2,3 left        NG                   
85 13686 28 F 173 d,e   1,2,3 right POS A 7 C. albicans NP       S S S S S 
86 13563 60 F 201 e   1,4,5 right       Cladosporium   NA NA   S  S  S S  S  
87 19738 40 F 205 c,e   1,4 right       A.niger   NH NHE   S  S  S S  S  
88 41120 21 F 206 b,c,e   1,2,4 left        A.niger   NH NHE   S  S  S S  S  
89 56798 19 F 207 c,d,e   3 right       NG                   
90 47427 17 F 210 g   2,3,4 right       NG                   
91 47247 28 F 213 e   2,4,5 right NEG D 10 C. krusei NP       S S NA NA S 
92 56597 13 M 215 d,g   2,4 left        NG                   
93 47124 37 M 222 e f 1,3,4 right       A.niger    NH HE   S  S  S S  S  
94 40697 47 F 224 b,c,e   1,4,5 left        NG                   
95 50766 21 F 225 e,g   1,2 left        A.niger    NH NHE   S  S  S S  S  
96 46246 19 F 226 b,d,g   1,2,3,5 left        NG                   
97 48624 5 M 227 c   1,3,4 left        A.niger   NH NHE   S  S  S S  S  
98 40639 58 F 228   f 2,3,5,6 right POS A 7 C. albicans P        S S R S S 
99 10562 28 M 229 d   1,2,3 left        NG                   
100   6016 35 F 230 e   1,4 left        A.niger   NH NHE   S  S  S S  S  
101 46375 27   233 b,g   3,4,5 bilateral       NG                   
102 41843 20 F 234 e   3,4 right       NG                   
103 18607 50 F 235 a,c,e   1,3,5 right       NG                   
104  9024 8 F 236 b,c,e   3,5 right       NG                   
105 19106 14 F 237     2,3,4 left        NG                   
106 40630 56 M 238 e,g   1,3,5 right       A.terreus   H HE B1,B2,G2 S  S  S NA S  
107 48935 40 M 239 a f 3,4,5 left  POS A 7 C. albicans P        S S S S S 
108 19339 54 F 240 e   2,3 left        NG                   
109 19028 34 F 241 c,e   2,3,4 right       NG                   
110     891 37 F 242 e,g f 2,3,4 bilateral POS A 7 C. albicans NP       S S S S S 
111 43590 34 F 243 b   1,2 right       NG                   
112 38910 24 M 246 b,c   2 right       NG                   
113 47103 21 M 247 d   1,2,3,4 left        A.fumigatus   NH HE   S  S  S S  S  
114 21020 54 M 248 c,e   1,4,5 left        A.niger   NH NHE   S  S  S S  S  
115 37554 40 F 250 b,c   1,4 left        NG                   
116  6172 43 F 251 e   2,4 right       NG                   
117 50155 26 F 252 e   2,3 left        NG                   
118 41443 55 F 254 e,g   1,2,5 right       A.flavus   H NHE   S  S  S S  S  
119 43556 24 M 256 e   1,2,5 left        NG                   
120 50906 34 M 257 b,e f 2,3,5 bilateral       NG                   
121 20893 58 M 258 a f 2,4 left        NG                   
122 50428 13 M 259 b,g   1,3,4 left        A.niger   NH NHE   S  S  S S  S  
123  8191 58 M 262 b,e,g f 2,4,5 right       A.niger   NH NHE   S  S  S S  S  
124 21433 22 F 266 c,e   3 right       NG                   
125 13978 19 F 267 c,e    1,4 left        Curvularia   NA NA   S  S  S S  S  
126 43541 34 F 268 e,g   2,3,4 left  POS A 7 C. albicans NP       S S S S S 
127 51116 17 M 269 e   2,3,4 right POS A 7 C. albicans NP       S S S S S 
128 25871 30 F 270     2,3,4 left        NG                   
129 46391 50 F 271 b,e   1,4 right       Rhizopus   NA NA   S  S  S S  S  
130 35333 59 M 273 a,b    2,3 right       NG                   
131 35925 42 F 274 b,e   1,4,5 left  POS A 7 C. albicans P        S S S S S 
132 34261 47 F 276 e   1,4 right       A.niger   NH NHE   S  S  S S  S  
133 32482 30 F 277 c   4 left        NG                   
134 50131 56 F 280 b,e f 1,4 right       NG                   
135 51507 34 F 281 c,e   2,3 right       NG                   
136  7286 49 F 284 b,c   2,3,4 left        NG                   
137 47887 26 F 287 a,c   2,3 right       NG                   
138 52253 64 M 290 b   1,4,5 right       NG                   
139 38737 17 F 291 a,c,g   3 left        NG                   
140  2060 42 M 292 e,g   1,4 left        A.niger   NH NHE   S  S  S S  S  
141 51177 28 M 295 b,e   1,4 left        A.flavus   H NHE   S  S  S S  S  
142 52837 31 F 296 e   1,5 right       A.niger   NH NHE   S  S  S S  S  
143 53007 38 M 298 b,e   1,3 left  POS A 7 C. albicans NP       S S S S S 
144  7549 60 F 301 b,g f 3,4 bilateral       A.niger   NH HE B1,G1,B2,G2 S  S  S S  S  
145 52046 17 F 303 e   2,3,4 left        NG                   
146 13417 7 F 304 e    2,3 right       NG                   
147 48918 23 F 312 b,e   1,3 right POS A 7 C. albicans NP       S S S S S 
148  1163 40 M 321 b,e,g   1,4,5 left        A.niger   NH NHE   S  S  S S  S  
149 44940 31 F 322 b,e   2,5 left        NG                   
150 52920 27 F 324 b,c,e,g   1,2,4 left        A.niger   NH NHE   S  S  S S  S  
151 40654 17 M 328 b,g   1 left        A.niger   NH NHE   S  S  S S  S  
152 55030 50 F 330 b,e   1,4 right POS A 7 C. albicans NP       S S S S S 
153 54138 21 M 333     3,4 right       NG                   
154 54326 14 F 334 b,e   1,4,5 left        A.flavus   H NHE   S  S  S S  S  
155 38361 60 M 335 c,e,g   2,4,5 right       A.niger   NH NHE   S  S  S S  S  
156 54923 30 F 337 d,e   1,3,4 left        A.niger   NH NHE   S  S  S S  S  
157 45012 40 F 341 b,c,e   1,2,3,5 right       Rhizopus   NA NA   S  S  S S  S  
158 49756 16 M 342 b,c   2,4 left        NG                   
159 54935 50 M 345 e   1,2,3 left        NG                   
160 57948 16 F 346     2,3,4 right       NG                   
161 61006 28 M 347 a,e   2,3,4,5 left  POS A 7 C. albicans NP       S S S S S 
162 41476 27 F 349     2,3,4 right       NG                   
163   4934 35 M 350 c   1,2,3,4 left        NG                   
164 48237 45 F 351     3,4 right       NG                   
165 61496 60 F 352 e   1,4,5 left        A.niger   NH HE B1,G1,B2,G2 S  S  S S  S  
166 10898 28 F 353 g   1,4 left        A.flavus   H NHE   S  S  S S  S  
167 54569 45 F 354 e,g   3,4,5 bilateral       NG                   
168 24827 42 F 355 b,e   1,4 left        NG                   
169 52197 15 F 356 b,e   1,2 right       A.flavus   NH NHE   S  S  S S  S  
170  4643 38 F 361 e   4 right       NG                   
171 65164 48 M 362 a   1,2,4 left        NG                   
172 14347 32 F 367     4 right       NG                   
173 31693 25 M 368 b,e   1,3 right       NG                   
174 65053 51 F 369 b,c   1,4 left        NG                   
175 41979 21 F 370     3,4 left        NG                   
176 65332 15 F 371 b   1,2 right       NG                   
177 65823 27 M 372     2,3 right       NG                   
178  9812 67 F 375 b,e   2,3,4 right       NG                   
179 56569 45 F 382 b,e   1,2,5 left  POS A  7 C. albicans P        S S S S S 
180 69330 36 F 394 c,e   2,  right       NG                   
181 25571 43 F 395 e   1,2,3,6 right       A.niger   NH NHE   S  S  S S  S  
182   1738 52 M 396 e f 2,4 left        A.flavus   H NHE   S  S  S S  S  
183 16546 19 F 397 c   2,3 left  POS A 7 C. albicans NP       S S S S S 
184 42415 32 M 398 b,c    1,2,3,5 right       Mucor   NA NA   S  S  S S  S  
185 34824 32 F 399 b,d   1, 4 right       A.flavus   H NHE   S  S  S S  S  
186  9478 23 F 400 b,e   1,4 right       A.flavus   NH NHE   S  S  S S  S  
187  6382 47 M 413 c    1,5 left        NG                   
188 61006 50 F 414 b,c   1,2,4,5 right       A.niger   NH HE   S  S  S S  S  
189 70312 65 F 415 a,b,c f 1,5 left        NG                   
190 1127 50 M 416 c   1,5 left        A.niger   NH NHE   S  S  S S  S  
191 71952 26 F 417 b   1,6 right       A.niger   NH NHE   S  S  S S  S  
192 72883 42 F 418 b,c   1,2,5 left        A.niger   NH HE   S  S  S S  S  
193  1839 27 F 419 c,e   1,2,5 left        NG                   
194 71004 40 F 421 e   1,2,4 right       A.niger   NH NHE   S  S  S S  S  
195 21563 68 M 422 b,c   1,2,4 left        A.niger   NH NHE   S  S  S S  S  
196 66943 80 M 423 b,c   1,5 right       NG                   
197  1846 33 M 430 c   1,4,5 left        A.niger   NH NHE   S  S  S S  S  
198 74385 18 F 435 a,c   2,3,5 right       NG                   
199 72904 23 F 444 e   1,2,4 right       A.niger   NH NHE   S  S  S S  S  
200  6848 25 F 479 c,e   1,3,4 right POS A 7 C. albicans NP       S S S S S 
 
